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ABSTRACT 
 
 
What mechanisms govern and maintain cell states during the process 
of differentiation is a pivotal question in science. What factors govern the 
commitment of developmental progenitors from pluripotent stem cells is a 
representative example of this question. Studies of transcriptional, signaling 
and chromatin regulation have been highly instrumental for elucidating 
mechanisms pluripotency maintenance. Nevertheless, current knowledge 
falls short in explaining the exit from pluripotency and its coupling to lineage 
commitment. It is unclear how pluripotency and differentiation become 
stabilized in a mutually exclusive manner.  
 
Here, I deepen our knowledge concerning post-transcriptional 
mechanisms in pluripotency-differentiation transition. For this purpose I first 
characterize by quantitative mass spectrometry the changes that occur in the 
mRNA bound proteome (RBPome) and identify extensive dynamic 
rearrangements of the RBPome during early embryonic development, from 
naive to primed stem cell state and to purified primitive streak progenitors 
(Chapter I). In parallel I identified developmental post-transcriptional 
processing landscape and show that the dynamic mRNA binding of the 
RNA-binding protein TDP-43 is critical in pluripotent stem cells (PSCs) for the 
choice between self-renewal and differentiation/ pluripotency breakdown 
(Chapter II). In detail, I discovered that TDP-43 directly regulates an 
evolutionary conserved switch in alternative polyadenylation (APA) of 
hundreds of transcripts during early differentiation of mouse and human 
PSCs. Functional analysis revealed that TDP-43 integrates into pluripotency 
circuitry by repressing the production of lengthened transcripts of the 
pluripotency factor SOX2, which is targeted for degradation by miR-21. 
Furthermore, in pluripotent stem cells TDP-43 also promotes self-renewal by 
repressing the formation of paraspeckles, membraneless nuclear 
compartments found only in differentiated cells, by enhancing production of 
short isoform of the lncRNA NEAT1. Conversely, reduction of TDP-43 during 
differentiation triggers a short-to-long isoform switch of NEAT1, which 
polymerizes paraspeckles that in turn recruit TDP-43 and relocalise it away 
from its other RNA targets. Consistent with this cross-regulation, TDP-43 
inhibits differentiation and improves somatic cell reprogramming, while 
paraspeckles promote early differentiation.  
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These findings reveal how the exit of pluripotency is regulated by a 
complex posttranscriptional network, which is functionally independent from 
lineage choices. Apart from its role in the exit of pluripotency, this cross-
regulation between paraspeckles and TDP-43 has implications in cancer and 
neurodegeneration.  
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ZUSAMMENFASSUNG 
 
Durch welche Mechanismen Zellen beim Differenzierungsprozess aus 
einem pluriputenten in einen spezialisierteren Zustand gelangen und wie die 
Zellzustände stabilisiert werden, gehört zu den Kernfragen der 
Stammzellforschung. Obwohl heute viele Faktoren bekannt sind, die die 
Differenzierung von pluripotenten Stammzellen in bestimmte Vorläuferzellen 
steuern, konnten die Studien, die sich der Transkription-, Signaltransduktion- 
und Chromatin-Regulierung widmen, Mechanismen zum Erhalt von 
Pluripotenz nicht völlig aufzeigen. Demgegenüber steht unser Verständnis 
davon, wie der konkrete Übergang aus der Pluripotenz in einen bestimmten 
Differenzierungsweg gelenkt wird, erst am Anfang. Wie gelingt es der Zelle 
aus einem stabilisierten Zustand der Pluripotenz einen wiederum stabilen 
Differenzierungsweg anzutreten, und wie interagieren dabei die 
Regulationsmechanimsen der sich gegenseitig ausschließenden Zustände? 
 
In meiner Studie analysiere ich die posttranskriptionellen Abläufe beim 
Übergang zwischen Pluripotenz und Differenzierung. Erst stelle ich Daten 
von mittels quantitativer massenspektrometrischer Verfahren charakterisierter 
mRNA gebundener Proteine (RBPome - mRNA bound proteome) vor in 
‘naïve’, ‘limes’  und ‘primed’ pluripotenten Stammzellen und in aufgereinigten 
Vorläuferzellen des Primitivstreifens, Zelltypen der frühen Differenzierung. 
Diese Ergebnisse zeigen umfangreiche dynamische Umstrukturierungen des 
RBPomes auf. In parallel dazu durchgeführten Arbeiten habe ich 
posttranskriptionelle Muster aufgefunden, die zellentwicklungsabhängig 
auftreten. Ich kann zeigen, dass eine dynamische mRNA-Bindung des RNA-
bindenden Proteins TDP-43 in pluripotenten Stammzellen besteht und für die 
Bestimmung zwischen den Selbsterneuerung einerseits oder Differenzierung 
/ bzw. Wegfall der Pluripotenz andererseits kritisch ist. Im Einzelnen konnte 
ich neue Befunde liefern, die belegen, dass TDP-43 einen evolutionär 
konservierten Schalter reguliert. Dieser steuert die alternative 
Polyadenylierung (APA) von Hunderten von Transkripten in der frühen 
Phasen der Differenzierung von murinen und menschlichen PSCs.  
 
Die funktionellen Analysen ergaben, dass man sich TDP-43 in einem 
Schaltkreis denken kann, der die Pluripotenz steuert. TDP-43 unterdrückt die 
Produktion von verlängerten Transkripten des Pluripotenzfaktors SOX2, die 
 
 
Introduction    
14 
sonst vermittels der Bindung von miR-21 zur Degradierung bestimmt wären. 
Des Weiteren wirkt TDP-43 auf den Erhalt der Fähigkeit zur 
Selbsterneuerung, indem es in pluripotenten Stammzellen die Bildung von 
Paraspeckles hemmt, - membranlose Strukturen im Zellkern, die nur in 
differenzierten Zellen gefunden werden. Dies geschieht über die Induktion 
einer erhöhten Produktion der kurzen Isoform der nicht-kodierenden RNA 
NEAT1. Auf der anderen Seite löst eine verminderte Expression von TDP-43, 
wie sie bei der Differenzierung vorgefunden wird, einen Isoform-Wechsel bei 
NEAT1 aus – hin zur langen Isoform. Dadurch polymerisieren Paraspeckles, 
und sequestrieren TDP-43, wodurch die Wirkung von TDP-43 auf andere 
Transkripte vermindert wird. Dementsprechend hemmt TDP-43 die 
Differenzierung und wirkt begünstigend auf Reprogrammierung somatischer 
Zellen, während das Vorkommen von Paraspeckles frühe Phasen der 
Differenzierung begünstigt. 
 
Die Erkenntnisse aus meinen Arbeiten weisen auf einen neuen 
postranskriptionellen Mechanismus hin, der den Ausgang der Pluripotenz 
funktionell unabhängig von der Entwicklungslinie reguliert, in die die 
Differenzierung der Zelle einmündet. Der beschriebene Mechanismus hat 
nicht nur Bedeutung für ein besseres Verständnis von Pluripotenz in der 
Stammzellforschung; vielmehr eröffnet die Erkenntnis über eine gegenseitige 
Regulierung von Paraspeckles und TDP-43 auch neue Ansätze in der 
Erforschung von Krebs und neurodegenerativen Erkrankungen 
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1 INTRODUCTION 
1.1 PLURIPOTENT STEM CELL MODEL 
 
Pluripotent stem cells (PSCs) are remarkable because they represent a 
basal stage of development that can be kept poised by self-renewal or 
differentiate upon stimuli. This enables detailed investigation of the 
fundamental molecular processes that govern embryogenesis. PSCs can be 
derived from inner cell mass (ICM) of preimplantation (blastocyst-stage) 
mammalian embryos or from somatic cells by forced reversion of 
developmental program of somatic cells, producing cell lines named 
embryonic and induced pluripotent stem cells (ESC/iPSC), respectively. Self-
renewal is the capacity of cell to proliferate in reprogramming state and 
pluripotency presents a potential of single cell to differentiate to all three cell 
lineages of the developing embryo and adult organism. 
 
1.1.1 Early embryonic development 
 
Early embryogenesis is highly dynamic process and includes a 
cascade of transitory pluripotent cell stages along the path from blastocyst to 
egg cylinder development and many can be captured at different time in 
early embryogenesis. Historically, two forms of pluripotency have been 
maintained thus far in vitro, termed naive and primed state (Brons et al., 
2007; Tesar et al., 2007; Ying et al., 2008). The most primitive state is mouse 
naive PSCs (nPSCs), which resemble in vitro “frozen in time” version of ~32 
pluripotent cells embedded within ICM of pre-implantation embryo (E3.5, Fig. 
1). These pluripotent cells are in vivo shielded by trophectoderm cells, 
together composing blastocyst (Rossant, 2008).  Under proper culture 
conditions with addition of selected inhibitors, ICM derived cells are in vitro 
“locked” in the reprogramming state (Nichols and Smith, 2009; Ying et al., 
2008). One day later in development (E4.5) upon fertilization when the 
blastocyst matures, the mouse embryo reaches the uterine wall and implants 
into uterus (Dey 2004, Bedzhov 2014). At this stage this early state of naive 
pluripotency evolves into the primed pluripotent state of the egg cylinder 
epiblast resembling rosette formation of pluripotent cells centered in 
monolayer surrounding the cavity, the precursor of the egg cylinder. At this 
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stage peri-implantation rosette becomes responsive to the differentiation-
inducing signals of the gastrula (Bedzhov and Zernicka-Goetz, 2014).  
 
 
Fig 1. Overview of the early embryonic development.  
 
Following implantation, the embryo is composed of polarized cup 
shaped epiblast (pluripotent derivative of ICM) and the trophectoderm-
derived extra-embryonic ectoderm. This more committed “post-implantation” 
pluripotency state has been coined “primed” and retains the potential to 
develop into the three germ layers, but lack the reprogramming capacity and 
are unable to integrate into a preimplantation blastocyst. In developing 
embryo (E5.5), epiblast stem cells are restricted sub-popultion that is 
shielded from lineage specification (driven by Erk pathway activated by FGF) 
and retain upregulated Nanog (Lanner and Rossant, 2010; Nichols and 
Smith, 2009).  
 
 
1.1.2 Pluripotent stem cells phase transit ions 
 
In vitro, primed pluripotent cell lines can be derived either from mouse 
epiblast stage embryos (Brons et al., 2007; Tesar et al., 2007) or by 
commiting nPSCs to epiblast stem cells (EpiSCs) by treating them with FGF 
and Activin A (Joo et al., 2014; Kurek et al., 2015) (Fig. 2). Thus, nPSCs and 
pPSCs are the in vitro counterpart of ICM, rosette stage, and the epiblast, 
respectively.  
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Zona pellucida Embryo
Recovery
Im
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tio
n
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Figure 2: In vitro  generation of naïve and primed PSCs and their dif ferentiat ion 
to germ layer precursors. 
 
Importantly human PSCs are thought to be equivalent of mouse 
primed PSCs, sharing distinct epigenetic landscape and increased DNA 
methylation, X chromosome activation and prevalent use of the proximal 
enhancer element to maintain OCT4 expression (Choi et al., 2016; Gafni et 
al., 2013; Theunissen et al., 2014). It seems that derivation of naive hPSCs 
(nhPSCs) or conversion of hPSCs to an earlier naive-like stage is possible, 
but currently there exist a dispute over their classification (Dodsworth et al., 
2015). Improving the derivation and classification of hnPSCs is predicted to 
advance fundamental understanding of human development and aspects of 
cell differentiation, passaging, and low gene editing efficiency, as well as 
prospects for developing regenerative therapies using hPSC progeny. 
Understanding growth conditions of derived pluripotent lines is pivotal to 
model developmental progression as well as the utility of stem cells for 
research and regenerative. To date five publications reported conversion of 
hESCs to naïve state without the use of transgenes (Gafni et al., 2013; Huang 
et al., 2014; Theunissen et al., 2014; Wang et al., 2014). All studies rely on a 
protocol that closely relates to mouse naïve stem cell culturing condition; 
combination hLIF addition with simultaneous dual inhibition of MEK and 
GSK3b (Dodsworth et al., 2015). In addition human naïve PSCs require 
administration of competence factor FGF to block differentiation, providing 
evidence of distinct signaling requirements to safeguard pluripotency in 
naïve mouse and human ESCs.  
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Property Naïve or 
Ground state 
Limes Primed state or 
xEpiSC 
Embryonic tissue Early 
epiblast/blastocyst  
Embryonic rosette Egg cylinder 
Chimeras Yes Yes No 
Naïve markers Rex1, Nanog, Klf4, 
Nr0b1 
Rex1, Nanog, Klf4 Absent 
Specification markers absent Otx2 Fgf5, Otx2, Oct6 
XX status XaXa XaXa XaXi 
Response to 2i Self renewal Reversible state Cell death 
Response to Fgf5/Erk Heterogeneous 
differentiation 
Rapid differentiation Self-renewal/priming 
 
Table 1: Comparison of Naïve, Limes and Primed Pluripotent States 
 
 
1.1.3 Comparison of naïve and primed pluripotency 
 
While both, naïve and primed pluripotency cell stages are defined as 
pluripotent, several key features have been found to differ in naïve from 
primed PSCs, and have become criterions for the designating the respective 
states (Table 1). nPSCs share some of epigenetic features of blastocyst with 
presence of two active X chromosomes in female cells, high chromatin 
condensation and lack of bivalent domains. These are activating and 
repressing epigenetic modifications at the same genomic position and are 
signature of primed ESCs with “alternative pluripotency configurations” 
(Weinberger et al., 2016).  
 
However, differences do exist between naive and primed state with 
relation to the core pluripotency network. Primed PSCs maintain expression 
of Sox2 and Oct4 pluripotency transcription factors, but already lose “naïve 
factors” (Esrrb, Nanog, Klf2/4). In addition, activation amplitudes by distinct 
signaling pathways prompt the cells towards stem cell stage progression. 
FGF/MAPK-ERK signaling is particularly potent in promoting naive to primed 
state transition by inducing differentiation genes and inhibiting Nanog, and 
thus this pathway is kept inhibited for maintaining the naive state by MEK 
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inhibitors (Lanner and Rossant, 2010). Similarly, the Nodal/Activin-TGFβ 
pathway (through Smad2/3) drives naive to primed transition and 
subsequently promotes expression of differentiation genes. Conversely, 
Wnt/β-catenin pathway is held constitutively active in naïve ESCs by 
inhibiting GSK3β, in order to suppress of the pluripotency inhibitor Tcf3 (Cole 
et al., 2008), while in the primed state this pathway promotes differentiation in 
the direction of the primitive streak (Berge et al., 2011; Kim et al., 2013; 
Kurek et al., 2015). 
 
Historically, ES cells were derived on mitotically inactivated 
fibroblasts, in the presence of serum and LIF (Martin, 1981), which activates 
JAK-stat3 pathway (Smith et al., 1988), thereby enhancing expression of 
naïve factor Klf4 (Hackett and Surani, 2014). In conjunction, these pathway 
inhibitors can substitute serum for propagation of naïve PSCs, a recipe 
commonly known as 2i/LIF (Ying et al., 2008). On the hand, in vitro 
conversion of naive to primed state pluripotency involves exclusion of 2i 
(MEK and GSK3β) inhibitors, and addition of FGF together with Nodal/Activin 
(with or without LIF) (Guo et al., 2009). This is therefore taken as an indication 
that distinct signaling inputs safeguard pluripotency in nmPSCs versus 
nhPSCs (Fig. 3). 
 
Fig3: Signaling pathways mediating mouse naive and primed state self-
renewal and differentiat ion. 
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1.1.4 Novel intermediate pluripotency rosette-l ike state in vitro 
 
Single-cell transcriptome sequencing is an emerging technology that 
has been applied study the continuum process of intermediate pluripotent 
states transitioning ranging between naïve and primed extremes (Hough et 
al., 2014; Kolodziejczyk et al., 2015; Petropoulos et al., 2016). Accompanied 
with revision of transition of early embryonic development from symmetric 
hollowed sphere (ICM) to a polarized cup, Bedzhov and colleagues 
identified that embryos at peri-implantation stage form rosette-like structure 
(E4.75–E5.0) organized around small lumenal space (Bedzhov and Zernicka-
Goetz, 2014; Bedzhov et al., 2014). It is worth mentioning that collaborative 
study managed to establish rosette-like pluripotent cells in vitro and 
indefinitely maintain by inhibition of Wnt/β-catenin signaling in conjunction to 
active MEK signaling (Nagau et al., manuscript in preparation; Table 1). 
 
Taken together, interplay of Wnt and MEK signals dictate distinct 
pluripotency stages that are accompanied with extensive epigenetic 
(Galonska et al., 2015) and post-transcriptional changes (Results; chapter I 
and II). We used this model to investigate how signaling pathways feed into 
remodeling of RBP functions during the transitions from naïve over peri-
implantation to primed pluripotent stem cells functionally contribute to self-
renewal and commitment to early primitive streak progenitors, and how 
changes of signaling pathways functionally regulate the post-transcriptome 
during pluripotency cell state transitions.  
 
1.2 REGULATORY NETWORKS SAFEGUARDING PLURIPOTENT STAGE 
1.2.1 Pluripotency circuitry 
 
Understanding the mechanisms underlying self-renewal and 
pluripotency of stem cells has been the focus of numerous studies in recent 
years (Gonzales and Ng, 2016; De Los Angeles et al., 2015), particularly 
from the perspective of the transcriptional regulation of the pluripotency 
network governed by trinity of nuclear regulators, Oct4, Sox2, and Nanog 
(Ding et al., 2009; Masui et al., 2007; Mitsui et al., 2003; Pei, 2009; Vallier et 
al., 2009). Overexpression of later overcomes the LIF-STAT pathway 
requirement to safeguard pluripotency (Mitsui et al., 2003). Despite Nanog 
being essential for life and establishment of pluripotency in vivo, it is 
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dispensable during in vitro somatic cell reprogramming to iPS cells 
(Festuccia et al., 2012; Smith et al., 2016) and can be replaced by forced 
expression of Esrrb (Festuccia et al., 2012; Martello et al., 2012a, 2012b), its 
coactivator Ncoa3 (Percharde et al., 2012) or myriad of functional 
downstream factors that can replace core pluripotency network elements in 
maintainance (Schmidt and Plath, 2012) or establishment of pluripotency 
(Smith et al., 2016).  Nanog-, Oct4-, or Sox2 deficient ES cells lose 
pluripotency and differentiate into extraembryonic lineage (Masui et al., 2007; 
Mitsui et al., 2003; Nichols et al., 1998), suggesting that the pluripotency 
trinity is major regulator of the self-renewing state. Depletion of some factors 
that can compensate core pluripotency factors results in failed colony 
forming capability (Martello et al., 2012a; Yeo and Ng, 2013). Current 
understanding of molecular, transcriptional and functional properties of naïve 
ESCs makes them the best available approach to model the developmental 
“ground state” of pluripotency, very close to their in vivo counterparts 
(Hackett and Surani, 2014). 
 
1.2.2 Exit of pluripotency and early differentiation of pluripotent 
stem cells 
 
Stem cell fate is specified by a mutual interplay between self-renewal 
specific differentiation signals. To initiate differentiation, stem cells have to be 
forced out of self-renewal. Unearthing the molecular mechanisms that 
dissolve the program of self-renewal in pluripotent stem cells is crucial for 
understanding the fundamental transition from pluripotency to germ layer 
precursors (Fig. 2) that have the potential to give rise to functional terminally 
differentiated cells of our body for regenerative purposes. The transcriptional 
and epigenetic control of the pluripotent state has been elaborated in detail, 
and significant headway has also been made in understanding germ layer 
differentiation. Namely, every pluripotent stem cells can be induced into 
endoderm, ectoderm and mesoderm, recapitulating the early events in 
embryogenesis. The process of differentiation can be conceptually divided 
into two processes: exit from pluripotency and germ layer 
differentiation/lineage specification (Gonzales et al. 2015). Current 
knowledge does not explain well the process of exit from pluripotency, and 
how the initial non-pluripotent stage is stabilized before epigenetic 
modifications generate the differentiation tracks.    
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In this regard, high-throughput screening has over the recent decade 
identified over hundred of genes, primarily transcription factors, involved in 
the process of differentiation. This has been highly instrumental to decipher 
various functional pluripotency networks substituting OCT4-NANOG-SOX2 
cluster (Ding et al., 2009; Ivanova et al., 2006; Kagey et al., 2010) however, 
whether and how these factors initiate differentiation has largely remained 
unclarified. The process of differentiation can be conceptually subdivided 
into two major steps (Gonzales et al., 2015) composed of the process of exit 
from pluripotency and germ layer differentiation/lineage specification. 
Current knowledge does not explain well the process of exit from 
pluripotency, and how the initial non-pluripotent stage is stabilized before 
epigenetic tracks are set by modifications of the epigenome. Initial insights 
were unraveled by high-throughput screening approach, identifying dual 
specificity phosphatases in regulating exit of pluripotency via ERK signaling 
leading to nuclear clearance of TFE3 transcription factor (Betschinger et al., 
2013) (Fig. 4). 
 
 
Figure 4: Posit ive (blue) and negative (orange) regulators of naive 
pluripotency. Modif ied from Kalkan and Smith, 2014 
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1.3 POSTTRANSCRIPTIONAL CONTROL OF PLURIPOTENCY AND ITS 
DISSOLUTION  
 
In the background, major improvements of deep sequencing 
techniques and proteomics enabled studies hinting the existence of another 
complex layer of gene expression regulation on RNA level that can modulate 
pluripotency and lineage commitment. Our understanding of eukaryotic gene 
expression has been reshaped by considering regulation on the RNA level 
(posttranscriptional gene regulation) as a central point in gene expression 
(Licatalosi et al., 2009) roles in a wide variety of biological processes 
(Gerstberger et al., 2013; Mitchell and Parker, 2014). In particular, system-
wide studies showed that posttranscriptional regulation is critical for early 
development. Already in the earliest developmental stage, the zygotic 
genome is transcriptionally silent and development is guided by exclusively 
by regulation by maternally produced mRNAs and proteins that are loaded 
into the oocyte (Lasko, 2011). Post-transcriptional gene regulation by RBPs is 
the fastest and very effective way to adapt gene expression and change 
cellular responses in comparison to transcriptional regulation or signaling.  
The biological importance of RBPs is underscored by the fact that many 
human diseases result from RBP malfunction (Castello et al., 2013). RBPs 
determine RNA processing of pre-mRNA to mature mRNA that involves 
attaching a guanosine cap to the 5’ end of the nascent transcript, removal of 
introns and cleavage of transcripts at the 3’end followed by subsequent 
addition of multiple adenosine residues during polyadenylation. New 
experimental approaches based on high-throughput sequencing are 
challenging our insights into regulatory principles controlling gene 
expression and thereby cell fate with an effort to understand the functions of 
RBPs. Single RBP can regulate hundreds on mRNAs and in turn whole 
developmental pathways can be modulated.  
Numerous studies have recently clarified that gene expression in 
eukaryotes involves tight regulation on the RNA level ensuring that correct 
complement of mRNAs and protein quantities are produced in cells 
(Presnyak et al., 2015). Throughout the RNA maturation from transcription to 
translation, RNA is namely associated with a myriad of RNA-binding proteins. 
These RBPs play a critical role in many aspects of gene expression and 
different RBPs regulate the unique fate of related transcripts in a cooperative 
and combinatorial fashion. This staggering variety of posttranscriptional 
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regulation modes mediated by combination of RBPs is thought to determine 
the cohort of posttranscriptional modifications of RNAs (Fu et al., 2015), 
thereby dictating cell fate. RBPs even permit reversal of cell-fate decisions, 
allowing replenishment of stem cells by cells that have already committed to 
differentiate (Wright and Ciosk, 2013). 
1.3.1 RNA binding proteins in stem cell fate decisions 
 
It is thus likely that another mode of regulation plays a central role in 
regulating the process of exit from pluripotency. It was already demonstrated 
that post-transcriptional regulation accounts for nearly 75% of the changes in 
protein levels after differentiation induced by knockdown of the transcription 
factor Nanog (Ye and Blelloch, 2014). Furthermore, recent screening 
approaches (Leeb et al., 2014; Lu et al., 2013; You et al., 2015) identified 
RNA-binding proteins (RBPs) as modifiers of pluripotency (Ye and Blelloch, 
2014) indicating that RBPs are important for PSC differentiation. This became 
apparent in the context of PSCs and differentiation primarily through 
proteomics analysis of OCT4, SOX2, and NANOG interaction partners  
(Mallanna et al., 2010) (Fig. 5). This pluripotency interactome revealed that 
one third pluripotency trinity interaction partners are candidates or validated 
RBPs, and past studies have already confirmed that majority of proteins that 
interact with pluripotency trinity are essential regulators of self renewal. To 
study the posttranscriptional control of pluripotency dissolution, the studies 
from the Smith lab have been highly instrumental, discovering RBP PUM1 
that negatively regulate mRNA isoforms that are specific to nPSCs when the 
cells begin to differentiate (Leeb et al., 2014).  Also some other proteins 
(ESRP1, TRIM71 (Chang et al., 2012)) were hinted to fine-tune expression 
level of pluripotency factors by binding to their mRNAs and very likely control 
their turnover by 5’UTR binding (Fagoonee et al., 2013). This indicates 
posttranscriptional regulation of mRNAs is fundamental for rapid dissolution 
of the naïve apparatus of nPSCs. 
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Figure 5: RNA binding factors that physically interact with core pluripotency 
transcription factors (OCT4, SOX2, and NANOG) are labeled in orange and putative 
RBPs are labeled in blue. Modified upon Mallanna et al., 2010. 
 
1.3.2 Pluripotency regulation by alternative splicing 
 
Alternative splicing results from variant recognition of the splicing 
signals, which can lead to skipping of alternative exons. Since most 
alternative exons are located within the coding region, alternative splicing is  
widely used mechanism for increasing coding diversity. Alternative pre-
mRNA processing plays a central role in defining cell state and tissue 
specificity, since most human genes are processed in a cell type and tissue-
specific manner (Licatalosi and Darnell, 2010). Recently numerous findings 
are unearthing distinct post-transcriptional landscape required for 
maintenance of pluripotent nature of PSCs. f.i. fundamental differences in 
patterns of alternative exon usage were observed between ES cells and 
differentiated cell types and tissues (Han et al., 2013). Also important 
pluripotency factors (Nanog, Sall4, Tcf3) encode various isoforms that are 
not all essential for maintaining pluripotency (Ye and Blelloch, 2014). Already 
skipping of stem cell specific exon of Foxp1 is sufficient to drive stem cell 
differentiation (Gabut et al., 2011). Blencowe and Ng labs showed that MBNL 
and SON proteins in general repress the generation of a cassette of gene 
mRNA binders
Putative mRNA
binders
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isoforms characteristic of human PSCs (Lu et al., 2013) and in detail repress 
ES-cell-switch exon of Foxp1 (Han et al., 2013) (Fig. 6).  
 
 
Figure 6: RBPs involved in pluripotency act on many regulatory steps. Negative 
pluripotency regulators are depicted in italic. 
 
1.3.3 Pluripotency regulation by alternative polyadenylation  
 
Alternative RNA cleavage site usage, better known as alternative 
polyadenylation (APA) generally regulates the length of 3’-UTRs. According 
to latest estimates, 70% of human genes undergo APA resulting in different 
3’ends with different length of 3’-UTR (Derti et al., 2012) and such extensive 
regulation is enabling tissue specific expression of ubiquitously transcribed 
genes (Lianoglou et al., 2013). On top of this, APA lead to altered 
translational efficiency (Bava et al., 2013) or affect the mRNA stability and 
localization  (Danckwardt et al., 2008) without changing the mRNA coding 
potential. Although isoforms with different length of 3’UTRs are producing the 
same protein, APA can even differentially determine the localization of 
proteins with different functions dependent 3’UTR usage (Berkovits and 
Mayr, 2015). The length of 3’-UTRs has important biological functions as it 
also in this way increases coding diversity and has implications in cell 
metabolism and disease development (Mayr and Bartel, 2010). Since 3′-
UTRs harbor miRNA-binding sites, shortening of 3’ UTR may lead to the loss 
of such regulatory elements making these short isoforms less prone to mRNA 
degradation and translate more efficiently. This can cause an increase in 
oncogene expression via APA. Recent studies support that cancer cell lines 
often express substantial amounts of mRNA isoforms with shortened 3′-
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UTRs. Such phenomena can also be observed in other proliferating cells 
such as T lymphocytes (Sandberg et al., 2008) and IPS cells in the process 
of reprogramming of somatic cells (Ji et al., 2009). Therefore, the proliferation 
and differentiation status of a cell seem to be tightly associated with its APA 
profile. Lately, more studies are presenting how APA plays a crucial role in 
many biological functions. The key regulators, extend and biological roles of 
APA during stem cell differentiation are to date unclear and it is generally 
unknown what controls exit of pluripotency and in particular what 
mechanisms are employed by the relevant RBPs on a transcriptomic level to 
regulate pluripotency breakdown.  
 
Multiple RBPs function in concert to dictate alternative polyA selection. 
We have uncovered principles how TDP-43 is committed in this process. 
TDP-43 protein is involved in several layers of mRNA life cycle, both in 
nucleus and cytoplasm. In nucleus they play a role in regulating alternative 
splicing (Lukavsky et al., 2013; Tollervey et al., 2011a) and as we show, it is 
essential for alternative 3’end processing as well (Eréndira Avendaño-
Vázquez et al., 2012). Apart from splicing, TDP-43 acts in several different 
regulatory steps; TDP-43 was originally identified as transcriptional inhibitor 
of assembly of general transcription factors on the TATA long terminal repeat 
of the HIV-1 genome, thereby inhibiting transcription of the TAR DNA element 
(Ignatius et al., 1995). Binding of TDP-43 regulates mRNA stability as well. 
That was presented by TDP-43 binding to 3’UTR of human low molecular 
weight neurofilament (hNFL) promotes stability of these transcripts. Recently 
it was reported that by regulating its own protein levels, TDP-43 might 
directly or indirectly affect TDP-43 transcription (Eréndira Avendaño-Vázquez 
et al., 2012).  
 
1.3.4 miRNA regulation of pluripotency and early stem cell 
differentiation 
 
There are mounting evidence that specific miRNAs play crucial roles 
in regulating myriad of cellular processes, including stem cell differentiation. 
Loss of Dicer, central processor of dsRNAs into mature miRNAs, causes 
severe defect in stem cell differentiation (Kanellopoulou et al., 2005). 
DGCR8, an RNA-binding protein that assists the RNase III enzyme Drosha in 
the miRNA biogenesis, results in silencing of mESCs self renewal (Wang et 
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al., 2007). Introduction of let-7 miRNA into Dgrc8 KO but not into wt mESCs 
rescues differentiation potential and suppress self-renewal. This indicates 
that precise control of let-7 is essential in facilitating stem cell differentiation. 
While primary transcripts of let-7 (pri-let-7) family is unchanged through 
development; rather, a post-transcriptional regulatory mechanisms prevent 
accumulation of the mature miRNAs in undifferentiated stem cells and 
pluripotent embryo. Namely pri-let7 family is uniformly expressed during 
embryonic development, however mature let-7 miRNAs is found only in 
differentiated cells (Heo et al., 2008; Suh et al., 2004), indicating a regulation 
on a post-transcriptional level. Indeed, LIN28 proteins were identified to 
control processing of let-7 family on several layers of miRNA biogenesis. 
Primarily LIN28 proteins were thought to regulate let-7 processing by binding 
to conserved stem loop motif (Wilbert et al., 2012) to recruit TUTase4 (Heo et 
al., 2008) and in concert mediate 3’ terminal uridylation of pre-let7. Such 
modified precursor transcript is refractory to processing by Dicer and is in 
turn degraded by exonuclease Dis3l2 (Chang et al., 2013). Additionally, by 
unknown nuclear mechanism LIN28 may inhibit Drosha processing, which is 
necessary to cleave the primary transcript into the pre-miRNA hairpin 
(Newman et al., 2008). This sheds some light on possible let7-dependent 
nuclear role of LIN28A, confirmed by recent identification of novel LIN28A 
binding sites to pri-let7 (Stefani et al., 2015).  Independent of its role in let-7 
biogenesis, LIN28A promotes translation of pluripotency promoting factors 
(especially OCT4)(Cho et al., 2012; Wilbert et al., 2012). Similar function has 
been observed for interaction partner of LIN28 (L1TD1) suggesting it acts in 
complex with LIN28, thereby facilitating binding to mRNA to influence levels 
of OCT4 (Emani et al., 2015).  
 
 
1.3.5 Post-transcriptional regulation by noncoding RNAs 
 
It is becoming evident that a large group of RNAs, arbitrarily referred 
to as long non-coding RNAs (lncRNAs), are functionally diverse, intimately 
involved in regulating transcription and in posttranscriptional processes. To 
name just few examples, lncRNAs have been shown to interact and 
potentially regulate and orchestrate the activity of proteins including, the 
Polycomb repressive complex 2 (PRC2) that modulate chromatin structure 
and accessibility for RNA transcription machinery (Mondal et al., 2015). 
lncRNAs have been shown to influence splicing decisions either directly by 
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forming RNA-RNA duplexes or by direct regulation of splicing factors 
(Gonzalez et al., 2015). In addition lncRNAs were found involved in 
regulating post-transcriptional RNA modifications through a diverse set of 
interactions ranging from acting as microRNA sponges to serving as 
scaffolds for higher-order complexes, such as ribonucleoprotein (RNP) 
particles (Du et al., 2016). Notably, lncRNAs have been indirectly linked to 
both gene activation and repression through the organization of nuclear 
subdomains; NEAT1, for example, have been shown to associate with 
interchromatin granules implicated in post- and -transcriptional regulation 
(Hirose et al., 2013). lncRNAs therefore can regulate transcription and 
transcripts through several mechanisms, and it has been postulated that our 
knowledge of the transcriptional regulatory mechanisms discovered thus far 
might just be the “tip of the iceberg, with additional means of lncRNA-
mediated transcriptional regulation to be uncovered” (Geisler and Coller, 
2012, Amaral et al., 2008). Considerable knowledge has been gained about 
NEAT1, crucial scaffold component of subnuclear structures termed 
paraspeckles (Fox et al., 2002) Two NEAT1 isoforms exist, short isoform – 
NEAT1v1, (MENβ; 3 kb) and long isoform – NEAT1v2 (MENε; 23 kb), both 
sharing the same 5`region, but only long isoform can polymerize 
paraspeckles (Clemson et al. 2009, Sasaki et al. 2009). While the middle part 
of NEAT1v2 localizes to paraspeckle core, its 3` and 5` ends as well as 
NEAT1v1 transcripts are found at the periphery (West et al., 2016). 
Paraspeckles were initially regarded as non-crucial nuclear domains 
(Nakagawa and Hirose, 2012) due to the generation of mouse NEAT1 
knockout that seemed normal (Nakagawa et al., 2011), but thus view is now 
changing with the studies implicating paraspeckles in female sterility and 
lactational defects (Nakagawa et al., 2014). Also, the importance of 
paraspeckles may differ between mouse and human, also since the latter 
contains Alu inverted repeat sequences, which are present only in higher 
primates and were shown to serve as paraspeckle retention signal (Chen et 
al., 2008). The link between paraspeckle functions and regulation of 
developmental processes has not been fully established yet, but it is enticing 
to speculate that at least for the case of exit from pluripotency there are 
strong indications for paraspeckles’ central role as paraspeckles are absent 
in PSCs (both in human and mouse), but form rapidly upon differentiation, 
and are present in all non-pluripotent cell types and in all mammals tested to 
date.  
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Figure 7: Paraspeckles are subnuclear foci built upon transcription of long isoform of 
lncRNA Neat1 containing myriad of RNA binding proteins, including TDP-43. 
 
Majority of the proteins confirmed to localize to paraspeckles are 
involved in splicing and other post-transcriptional processes that are 
fundamentally important for control of early differentiation, even the 
paraspeckle core components (Ma et al., 2016). This proposes an existence 
of a high-order orchestration of posttranscriptional processes involving 
multiple RBPs. It is enticing to speculate that in this regard paraspeckles are 
particularly important and function as global hubs for post-transcriptional 
regulation. The fact that signaling pathways have tight control over early 
developmental stages, as demonstrated in great detail for the mouse ESC 
system (Fig. 3) raises the intriguing question of whether the same 
biochemical cascades directly govern stem cell differentiation. How changes 
of the cohort of RBPs functionally regulate the co- and post-transcriptome 
during pluripotency cell state transitions remains to be elucidated in detail, 
however paraspeckles mediated post-transcriptional regulation indicates 
existence of post-transcriptional hubs. 
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2 AIMS OF THE PHD THESIS 
 
The primary objective of my thesis is to identify mechanisms pertinent 
to posttranscriptional regulation that govern exit of pluripotency. The 
understanding of PSC biology is fundamentally important because these 
cells provide us a proxy system to address key questions regarding early 
human development, and from the medical perspective, we can use 
knowledge to produce progeny for regenerative therapies and for modeling 
disease in the dish. My approach relies on global characterization of 
posttranscriptional changes that take place upon commitment of PSCs and 
their early differentiation, followed by detailed mechanistic studies. The 
importance of posttranscriptional regulation is evident because the copy 
numbers of transcripts can only partially explain the quantity of the 
respective proteins.  
 
How are RBPs involved in rapid dissolvent of the self-renewing 
reprogramming apparatus in PSCs is to date unknown. To deepen our 
knowledge concerning post-transcriptional mechanisms governing 
pluripotency transitions and breakdown of the pluripotency circuitry, I 
first aimed to identify global changes in alternative polyadenylation (APA) 
during stem cell differentiation. Upon discovering differentiation-induced pre-
mRNA processing changes, I took a candidate approach to identify RBPs 
that maintains pluripotency or such that dissolve this state by promoting 
specific post-transcriptional landscapes. To gain direct mechanistic 
knowledge about respective RBPs, I went on to analyze what cis-acting 
elements in the UTRs that recruit RBPs, and how this regulates gene 
expression. Finally, I conducted functional 3’end processing analyses of 
RBPs to prove their link to developmental states. The specific aims of my 
study therefore include: 
1. To globally identify the alternative polyA-sites and what 3’ end 
processing rearrangements take place upon change of cell fate. In 
this context the choice of PSCs is highly advantageous from the 
perspective that discrete developmental stages can be propagated 
and purified in vitro, termed naive and primed states, and purified 
developmental progenitors that exhibit mesoderm and endoderm 
characteristics. 
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2. To identify clustered enrichment of regulatory motifs around 
developmentally regulated polyA sites. This premise is guiding me 
because RBPs typically bind to such clustered motifs and currently a 
compendium of 114 human/mouse RBPs has experimentally defined 
binding motifs1. 
 
3. To identify key regulatory RBPs involved in the dismantling of 
pluripotency and/or promotion of lineage commitment. This can be 
done using information about predicted RBPs according to their 
known binding motifs, and by integrating mRNA-sequencing data with 
experimentally defined RBP binding sites by iCLIP.  
 
4. To decipher the biological functions of APA and influence of RBPs on 
pluripotency and/or differentiation, i.e. how are RBPs promote and 
dissolve the self-renewing reprogramming state. 
 
5. To further empower identification of developmentally essential RBPs I 
aimed to identify changes that occur in the RNA binding activity of 
compendium of RNA binding proteins during subsequent steps of 
differentiation, from naive to primed stem cell state and to purified 
progenitors exhibiting mesoderm and endoderm characteristics. In 
this context my aim is to focus on changes of RBP activity that is 
mediated by alternations of the binding propensity rather than to the 
RBP levels in the cells. 
 
 
From the methodological perspective, my intention here is to integrate 
high-throughput sequencing approaches with RBPome capture coupled to 
global proteomics analysis as well as biochemical and functional assays for 
unearthing how the post transcriptional layer of gene regulation governs 
developmental stages, particularly those pertinent to the pluripotency 
circuitry.  
 
By such integration approach I aimed to identify developmental RBP 
rearrangements to create a model centered on sequestration of the 
pluripotent state and stabilization of differentiation poised state through the 
 
 
                                            
1 (http://rbpmap.technion.ac.il/RBPmap_motif_list.html) 
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concert action. One such hub that has been implicated in post-transcriptional 
regulation in concert action are nuclear membraneless granules termed 
paraspeckles. It should be noted that I have set here to address my 
hypothesis regarding the function of the paraspeckles, which have been 
reported to exist only in differentiated cell types, but not in undifferentiated 
PSCs. Although the full composition and cellular functions of paraspeckles 
have yet to be clarified, they have been implicated in post-transcriptional 
regulation by association with RBPs. I therefore reason that paraspeckles are 
at the center of a crosstalk between RBPs, global post-transcriptional 
regulation and developmental stages. I therefore aim to elucidate 
mechanisms of paraspeckles formation and to uncover how paraspeckles 
regulate pre-mRNA processing which I suspect that they promote 
differentiation. It is my ultimate goal to create a model centered on 
sequestration of pluripotency factors and stabilization of differentiation 
poised state through the concert action of hubs of RBPs and RNAs. 
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3 RESULTS 
3.1 DEVELOPMENTAL ONTOGENETIC RBPOME DURING EMBRYONIC 
STEM CELL PRIMING AND EARLY DIFFERENTIATION  
 
3.1.1 Recapturing early embryonic development in vitro 
 
Early embryogenesis in mammals encompasses a cascade of 
transient pluripotency states along the path from the blastocyst to the 
epiblast stage. Many studies have dealt with signaling requirements for 
maintenance of h/m naive and primed state PSCs, and uncovered an 
interplay of underlying Wnt and MEK signals (Figure 2) (Bernemann et al., 
2011; Joo et al., 2014; Kurek et al., 2015) Kojima et al., 2014). In addition, 
Wnt signaling has been shown to promote the formation of the primitive 
streak in mouse embryos or a similar fate in vitro (Drukker et al., 2012; Kim et 
al., 2013; Kurek et al., 2015). As a preparatory step to study the function of 
RBPs in development in the context of posttranscriptional modifications that 
govern cell fate, I established protocols for preparation of homogeneous 
preparations of h/mESCs along the commitment path from naïve pluripotency 
to primitive streak-like progenitors. 
 
3.1.2 Identif ication and isolation of naïve-primed pluripotency 
transit ioning states 
 
To take an advantage of the most advanced staging system of 
pluripotent states, I established culture systems allowing propagate three 
stages of pluripotency according to unpublished data of the ten Berge lab 
(Erasmus MC). In collaborative work with the laboratory of Derk ten Berge we 
sought to identify whether Wnt or MEK signals regulate the transition to the 
intermediate state of pluripotency found in the embryonic rosette, using an 
ESC-based model for rosette formation. Together we demonstrated that 
rosette-stage pluripotency (Fig. 1) can be indefinitely maintained in vitro by 
inhibiting Wnt/β-catenin signaling in conjunction to active MEK signaling. 
Immunostaining confirmed that rosette-like cells (termed Limes) undergo 
lumenogenesis, with the cells arranged in a monolayer surrounding the cavity 
stained by sialomucin podocalyxin. Additionally, limes cells express naïve 
marker Klf4 and but are lacking primed marker Oct6, indicative for epiblast 
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stem cells (Fig. 8), but are already expressing early stem cells priming factor 
Otx2.(Fig 9A-B). 
 
 
Figure 8: Wnt signall ing and Mek inhibit ion regulate entry to and exit from the 
l imes rosette stage. 
(A) Rosettes generated by ESCs 48 hrs after seeding in Matrigel in the indicated conditions 
using naïve pluripotency conditions (2iLIF) or individual inhibitors: CHIR99021 (GSK3 
inhibitor),  PD0325901 (MEK inhibitor), IWP2 (Wnt pathway inhibitor) or by adding Wnt3a 
recombinant protein. Seeded cells were stained for the indicated markers of pluripotency 
(Klf4, Oct4), stem cell priming (Oct6), lumen formation (Podocalyxin), or actin cytoskeleton 
(Actin) to label polarized rosettes (courtesy of Derk ten Berge).  
 
In an additional set of experiments, we corroborated the limes stage 
classification by quantifying the protein content of these cells. Using 
quantitative proteomic measurements we found that markers of naive 
pluripotency including NANOG, ESRRB, REX1, KLF4 and STELLA (DPPA3) 
are expressed at similar protein levels also in limes cells (Fig. 9A,C), with 
exception of UTF1 and LIN28A, which were recently identified as first factors 
that respond to withdrawal of 2iLIF conditions (Galonska et al., 2015; Kalkan 
et al., 2016). In addition to retained naïve pluripotency circuitry, the 
proteomics data confirmed that limes PSCs express comparable levels of 
OTX2 as primed PSCs (EpiSC) (Fig. 8B). In contrast to naive and limes stage 
pluripotency, primed state EpiSCs exhibit an alternative pluripotency 
configuration that lacks naive markers, but also markers associated with 
early germ layers such as FOXA2, EOMES, T and SOX17 (Fig. 9B). 
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Fig. 9. Limes cells represent an intermediate state of pluripotency.  
(A) Immunostaining for the indicated markers plated in limes MEK/Wnt-inhibited conditions 
containing Lif, PD325901 and IWP2. (B) MS-count (log2) heat map of proteins markers of 
naïve pluriptency (NANOG, ESRRB), pluripotency factors (OCT4, SALL4, E-CAD), early 
priming factor OTX2 and lineage specifiers (EOMES, SOX17, FOXA2). (C) A representative 
flow cytometry diagram of Nanog-eGFP reporter line maintained in naïve, limes and primed 
pluripotency culturing condition. 
 
To observe commitment potential of novel pre-implantation 
pluripotency layer, I exposed naïve ESCs and limesSCs to a medium 
containing ActivinA, FGF2 and the Wnt inhibitor IWP2, which promote 
conversion of naive PSCs to pried state. I observed accelerated 
differentiation potential of limesSCs that lose expression of naïve pluripotency 
markers within 24hrs of stem cell priming. In contrast naïve PSCs revealed 
depletion of naïve markers first upon 72hrs of priming (Fig. 10). This indicates 
that limesSCs occupy a bordering state of pluripotency that occurs during 
the intermediate phase of the naïve to primed pluripotency transition. 
 
Collectively results indicate that absence of Wnt signals with 
simultaneous MEK inhibition progresses naïve PSCs towards the 
pluripotency intermediate state of naïve-primed transition with similarities to 
the rosette stage in embryo development. These stably maintained limes 
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cells are in vitro counterparts of the embryonic rosette co-expressing naïve 
and primed pluripotency markers. 
 
 
Fig 10: Exit from pluripotency comparing naive and l imes PSCs.  
A representative flow cytometry analysis of Rex1-d2GFP reporter during a time course 
treatment by priming medium of limes (above) and naïve PSCs (below). Accelerated 
commitment potential of limes PSCs indicates that limes PSCs are homogenously 
accumulated at the edge of the naïve-primed transition.  
 
 
3.1.3 Isolation of early primitive streak-l ike progenitors  
 
As a further preparation for analyzing post transcriptional processes 
using differentiated PSCs I optimized a protocol to generate progenitors that 
resemble nascent primitive streak (PS) cells. I utilized a double reporter 
mESC line modified to express distinct fluorescent proteins regulated by the 
promoters of T (Brachyury) and Foxa2 genes. The expression of T and Foxa2 
alone is indicative of mesodermal and endodermal commitment, respectively 
(Burtscher and Lickert, 2009; Wu et al., 2015) (Fig. 11).  
 
In accordance with recent findings that Fgf/ActA treatment is not 
optimal for long-term maintenance of EpiSCs (Kurek et al., 2015; Wu et al., 
 
 
Results    
38 
2015), I observed that historical EpiSCs derived without IWP2 (Tesar et al., 
2007) exhibit promiscuous differentiation with high degree (~70%) of T/Foxa2 
positive cells, while addition of IWP2 suppressed lineage differentiation (Fig. 
11) and maintained the cells in pluripotency state as indicated by SSEA1 
pluripotency marker expression (Fig. 12).  
 
Fig. 11. Differentiat ion of dual reporter Foxa2-RFP  T-eGFP  EpiSCs.  
Flow cytometry diagrams of cells treated with the indicated factors and analyzed according 
to the relevant fluorescent emissions. Cells were maintained in the presence of IWP2 prior to 
the experiment and vehicle stands for bFGF ActA basal medium.  
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Next, I confirmed that treatment by Wnt3a leads to a rapid 
upregulation of genes associated with the formation of primitive streak (Kurek 
et al., 2015). Following 24hours of Wnt3a-driven differentiation I noticed the 
formation of progenitors with mesodermal characteristics (T-eGFP+), then 
double positive cells and lastly upon 3days of EpiSC differentiation the 
formation of Foxa2-RFP+ populations with endodermal characteristics (Fig. 
11). This confirms the dynamic expression of these markers in the primitive 
streak as the embryo undergoes gastrulation as the T expression represents 
an early event in gastrulation where this gene is expressed in the proximal 
posterior region of the embryo, while FOXA2 is an anterior marker (Burtscher 
and Lickert, 2009).  
 
Finally, to confirm the transition from pluripotency to PS progenitor 
phenotype I performed mRNA sequencing (QuantSeq). This confirms 
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Fig 12: Foxa2-RFP T-GFP EpiSCs 
are pluripotent.  
Flow cytometry plots of Foxa2-RFP T-GFP 
EpiSCs analyzed for pluripotency marker 
SSEA1. The cells were maintained in 
medium containing ActivinA, bFGF and 
IWP for 5 or 7 passages as indicated.  
 
F ig 13: Express ion heat map of main 
naïve pluripotency factors (Nanog, Esrrb, 
Klf4, Dppa3, Utf1), core general 
pluripotency network (Pou5f1/Oct4, Sox2 
and Lin28a), epithelial and pluripotency 
marker E-cadherin (Cdh1), earliest priming 
factor specifying limesSCs (Otx2) and 
lineage specifiers (Eomes, T, Foxa2).  
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maintainance of naïve pluripotency network (Nanog, Esrrb, Klf4, Dppa3, Utf1) 
and expression of early priming factor Otx2 in limesSCs (Fig. 13). 
 
3.1.4 Alternative polyadenylation changes accompanying early 
PSC differentiation 
 
To understand in a greater detail post-transcriptional changes that 
underlie transitions between pluripotency stages and to primitive streak 
progenitors, I characterized the global APA landscape in naive, limes and 
epiblast PSCs as well as earliest primitive streak like T-eGFP+ (PS)-
progenitors that were produced as outlined above and sorted (Fig 11). I 
globally analyzed the polyA site (PAS) locations in these populations by 
expressRNA analysis tools (Gregor Rot et al., 2017). I observed a general 
trend towards lengthening of transcripts during the transition between 
pluripotency stages to PS progenitors (Fig. 14A), and identified >400, >700 
and >1000 alternatively polyadenylated transcripts comparing naïve, to 
limes, EpiSCs and Brachyury+ sorted progenitors, respectively (Fig. 14B). 
This indicates that RBPs, which regulate APA may be important for transitions 
between pluripotency stages and differentiation.  
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Fig. 14. Developmental alternative polyadenylation.  
(A). A density plot depicting the direction and degree of APA upon pluripotency transitioning 
and primitive streak specification (genes exhibiting APA, p<0.01, Fisher’s exact test, n=5). 
(B) The degree of lengthening or shortening per gene detected by global 3’RNA-Seq in 
mouse naïve, limes, epiblast PSCs and T-GFP progenitors. Each dots depicts individual 
regulated transcript.  
 
Defined developmental populations provided an insight into cohorts of 
RBPs that are specifically expressed in continuum of pure pluripotency 
cultures of naïve-limes-epiblast PSCs, and sorted homogeneous progenitor 
populations that emerge from epiblastPSCs, presenting a foundation for 
functional analysis of the leading candidates for the respective 
developmental pre-mRNA processing changes. In an attempt to explain the 
observed altered developmental APA landscape, we next compared the 
protein levels of known polyadenylation (Fig. 15A-B) and splicing factors 
(Fig, 15C) in the respective stages. Interestingly, we failed to identify 
significant changes between abundances of polyadenylation or splicing 
factors (Fig. 15A-C) in early pluripotency transitioning, which are not dynamic 
to similar degree as observed for transcription factors (Fig. 15D).  
 
 
Fig 15: Protein abundances during stem cell  transit ions and early primit ive 
streak differentiat ion.  
(A-C) Quantitative MS identified protein changes during naïve->limes->EpiSC->primitive 
streak (T-eGFP+) cell transitions for RNA splicing factors (A), general polyadenylation 
factors (B), all RNA processing factors (C) and general transcription factors (D).  
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This indicates that the rearrangement of the RNA processing 
landscape during pluripotency transitions may be uncoupled of the protein 
amounts of RNA splicing and processing factors. I thus hypothesized that 
RBPs can regulate observed RNA processing changes independent of 
protein amount by dynamic changes of RBP localization, changes in 
interaction partners of the candidate RBP or its post-translational 
modifications. To uncover changes in the RNA-binding activity of RBPs I set 
out to generate ontogenetic mRNA-RBP occupancy assay (RBPome) that 
represents changes that take place during early embryonic development.  
 
3.1.5 Analysis of the RBPome in PSC states and early 
differentiation 
 
 To uncover the changes in composition of the RNA-bound proteome 
and the rearrangements that occur in the cohorts of RNA binding proteins 
bound to mRNAs - termed RBPome - during early embryonic development I 
modified protocols of RBPome capture and analysis by liquid 
chromatography–mass spectrometry (LC-MS) to the scale of several million 
of cells per sample (Fig. 16). This is because 10^7 cells is the upper limit 
amount of developmental progenitors that can be readily purified by FACS, 
while existing protocols for RBPome LC-MS analysis utilize >5^9 cells per 
sample (Baltz et al., 2012; Castello et al., 2012; Kwon et al., 2013; 2016). 
Briefly, I eliminated RNAse digestion of bound RNPs (RNase masks RBP 
peptides) by instead employing filter aided sample preparation (FASP) on-
filter-digestion of the proteins with LysC and trypsin (Zougman et al., 2009), 
and utilizing stringent washing steps. Additionally, I implemented recently 
published improvements of the mRNA-interactome protocol by increasing 
lysis temperature to 60°C and using higher DTT concentrations that allowed 
the complete removal of major contaminants such as Tubulin (Sysoev et al., 
2016).  
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Fig. 16. Schematic overview of 
the LC-MS RBPome analysis 
protocol. RNA-protein complexes 
were cross-linked by exposure of the 
cells to UV-C, followed by lysis, mRNAs 
were captured by oligo-dT coupled 
magnetic beads followed by stringent 
washing. Eluted RNPs were tryptic 
digested on-filter and prepared for MS 
measurments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To test whether the eluted proteins were indeed specifically bound to RNAs 
and were not contaminants associated with pulldowns, I carried out silver 
staining comparing proteins released from oligo-dT beads with or without 
prior RNAse-I treatment.I proveid that without the RNAse I treatment, the 
proteins that were eluted from mRNA capture oligo-dT beads were trapped 
in the gel while with RNAse digestion the proteins migrated into the gel (Fig. 
17A). In addition, I confirmed the enrichment of RBPs using this protocol by 
analyzing the bona fide RBP FUS compared to common contaminants such 
as Beta actin and Tubulin Alpha 1a (Fig. 17A). This proves that the oligo-dT 
eluted proteins are RBPs. 
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Fig 17: Validation of RBPome pulldown in 10^6 cells.  
(A) RBPome samples with RNase I treated or not, left and right, respectively.. Western blot 
(far right) analysis using antibodies that are specific to ACTB, TUBa1 and FUS. Samples are 
mouse naive/ epiblast ESCs. (B) Total peptides (above) and proteins (below) identified by 
MS-LS analysis of 1, 5 and 10 million naive mESCs and presented as Venn diagrams. (C) 
Scatter point-plot comparing the peptide counts of two RBPome technical replicates of 
EpiSC generated using 10mio cells. 
 
To determine the lower limit of the cell number for this protocol, I 
analyzed naive mESCs in the range of 5 to 20 million cells, and noted that the 
peptide/protein discovery rate was highly correlated even when analyzing 5 
million cells (Fig. 17B). Furthermore, my analysis shows that we can reach 
similar RBP discovery rate by utilizing samples with more than an order of 
magnitude lower amount of cells. To verify quantitative nature of RBPome 
capture we measured technical repetitions of LC-MS RBPome measurments 
and observed near perfect correlation (r2=0.993) (Fig. 17C). To confirm that 
robust identification of mRNA-bound proteome is quantitative we compared 
independent biological replicates. We observed near perfect correlation for  
RBPs between biological replicates (r2 = 0.953) (Fig 18A). 
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Fig 18:  Determining RBPome data integrity.  
(A) A scatter plot representing peptide counts detected by LS-MS of corresponding proteins 
in two EpiSC sample replicates. Blue and black marks correspond to annotated 
(Gersteberger et al. 2014) (r2=0.953) and novel RBPs (detected in this study, r2=0.906), 
respectively. The dashed line represents a linear correlation. (B-C) Peptides (blue) passed 
filtering if they are enriched by a factor of 2 or more compared to non-cross-linked and 
naked beads samples, left and right, respectively (adjusted P value < 0.01 Benjamini-
Hochberg method). (D) A scatter plot representing peptide counts detected by LS-MS of 
corresponding proteins in one EpiSC sample and one non-cross-linked sample. Blue dots 
represent proteins fulfilling criteria of statistical enrichment over both negative controls. Axes 
depict the number of unique peptide identifications. The dashed line represents a linear 
correlation.  
 
It is noteworthy to mention that measurements and analyses of sample 
series, including non-crosslinked and naked magnetic bead controls, were 
run in a single batch. This is because for label-free quantification, which is 
based on peptide peak intensities in extracted ion chromatograms, it is 
advantageous to measure all samples within one batch using similar UPLC 
trapping and separation columns in order to keep sample to sample 
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variations as low as possible. This is important particularly for assessment of 
RBPs that are enriched over the controls. Importantly, peptides derived from 
UV-crosslinked samples typically exhibited higher intensities than 
contaminants like trypsin and keratins, which also had similar intensities in 
non-crosslinked control preparations (Fig 18B).  To further strengthen a 
cohort of bona fide RBPome, I implemented additional control using mock 
pull-downs with control beads lacking oligo(dT) to eliminate not only proteins 
that unspecifically bind oligo(dT) but also common contaminants of magnetic 
beads (Fig. 18C). 
 
Further, running all samples in a single batch is important particularly 
for calculating changes that occur in mRNA-RBP occupancy during early 
differentiation as outlined below. After completing optimizing of RBPome 
capture and LC-MS analysis, I conducted differential mRNA-RBP occupancy 
analysis of homogeneous preparations of naïve-, limes- and primed-state 
mESCs and purified primitive streak progenitor population by sorting of T-
eGFP labeled cells. In total, I detected 4798 unique peptides from 853 
proteins, and of these 819 were consistently identified (2 of the 3 replicates) 
in all analyzed developmental stages. Of the latter, 676 proteins were 
enriched by a factor of 2 or more relative to both non-crosslinked and naked 
bead controls in at least one of the cell states, 440, 499 and 631 in naive, 
limes and epiblast PSC states respectively, and 387 in the T-eGFP 
population (Fig. 19A). 
 
 Finally I analyzed whole cell amounts (proteome) of the respective 
stages for normalizing out RBP-mRNA occupancy changes that are due to 
up- or down-regulation of RBP protein levels. Label-free proteome 
measurements were highly quantitative, exhibiting almost perfect correlation 
between replicates (coefficient r2=0.999). By applying a 2-peptide cut-off 
criterion I identified 3172 proteins in the total proteome measurements, and 
thereby I narrow down the list of 676 RBPs to 519 RBPs which were identified 
in both total ontogenetic RBPome and whole cell proteome datasets (Fig. 
19C). This set of 519 high confidence RBPs was used to compute what 
relative proportion of protein amount is identified in RNA bound fraction 
during cell fate transitions. A GO terms analysis of the final list indicates the 
expected enrichment of categories related to RNA processing (Fig. 19D). 
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Fig. 19. Proteomic analysis of ontogenetic RBPome. 
(A) A Venn diagram depicting the number of proteins identified with high-confidence 
(enriched over non-crosslinked and naked beads samples) in naive, limes and epiblast-
stage PSCs. (B) A Venn diagram depicting total RBPome list (naïve, limes and EpiSCs 
states) with the list of annotated RBPs (Gerstberger et al., 2014) and previously identified 
mESC RBPs grown in LIF and serum (Kwon et al., 2013). (C) A Venn diagram depicting 
RBPs (enriched over non-crosslinked and naked beads samples) with proteins identified in 
whole cell lysate proteome label-free MS analysis. The intersect of 519 proteins is further 
assigned for analysis. (D) Gene Ontology analysis of the ontogenetic RBPome related to (C). 
‘‘RNA-processing’’ and other RNA-related ‘‘GO terms’’ were enriched in RBPome compared 
to total/whole-cell lysate. 
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3.1.6 Ontogenetic dynamic RBPome 
 
As my primary goal is to identify RBPs that are directly regulated by 
signaling cascades during cell fate transitions from naive -> limes -> primed 
-> progenitor fates, I analyzed the changes in the mRNA-RBP occupancy 
(RBPome) between states relative to changes in their total amount between 
the respective states, which was detected by the whole-cell proteomics 
approach. This process is demonstrated for naive and epibalst PSCs (Fig 
20A). First, comparing the averaged levels of RBPs detected in RBPome 
between naïve and epiblast PSCs shows only small differences between the 
states (Fig 20A). Next, calculating the ΔRBPome values for these states and 
comparing to the ΔProteome values, shows a complex picture of RBP 
behavior (Fig. 20B, and C for naive and limes comparison), including  
Class 1: RBPs that do not exhibit abundance differences in the 
RBPome relative to their whole cell amount between the stages (~80%),  
Class 2: RBPs that exhibit correlated changes in both the RBPome 
and whole cell measurements (~10-13%), and  
Class 3: RBPs that exhibit changes in the RNA bound fraction 
(RBPome) but such that are not correlated with changes of their overall 
amount between the stages (~5-10%). Importantly, the latter class of proteins 
exhibits dynamic changes in mRNA binding affinity that doesn’t correlate to 
corresponding protein abundance of given RBP (Fig 20D) either upon 
transition from naïve PSCs to limes (Fig. 20B) or epiblast pluripotency state 
(Fig 20C).  
 
 
 
Results    
49 
 
 
Fig 20. Dynamic associations of RBPs during pluripotency state transit ions.  
(A) A scatter plot depicting averaged RBP intensities of naive and primed-state PSCs (n=3), 
respectively). Blue labels are previously annotated RBPs according to Gerstenberger et al. 
2014. Dashed line represents linear correlation. (B-C). A scatter plot depicting ΔRBP 
amount as detected by proteome or RBPome with respect to naive versus primed (B) or 
limes states (C) The x-dimension thus represents the difference in the expression level, while 
the y-dimension indicates the difference in mRNA-binding capacity Quantitative nature of 
both methods results in expected values on or near the blue dashed line dissecting 
quadrants. Proteins that aberrate from correlative proteome/RBPome abundances are 
characterized as dynamic RBPs (grey) upon limes commitment (B) or epiblast PSCs (C) 
priming. (D) A Volcano plot depicting proteins from (B) that were counted as dynamic RBPs 
(blue) if they show that difference abundance ratio naïve/epiblast of each protein in the 
RBPome versus its naive/epiblast abundance ratio in the total proteome is statistically 
enriched (P values were adjusted using Hommel method). (E). A venn diagram depicting the 
number of RBPs in analysis of pairs of states (with adjusted P values <0.01). 
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By analyzing the GO terms of the group of RBPs that collectively 
exhibits a change in RBPome without corresponding changes of expression 
levels (class 3), I found that they have an annotated role in regulation of 
translation process (Fig 21A).  In contrast, static RBPome (proteins with 
untaltered abundance of the mRNA-RBP occupancy) is enriched for RNA 
processing and regulation of gene expression. Of the RBPs that exhibit 
enrichment in the primed state (Fig. 21B), I noted in particular the 
pluripotency factor LIN28A, which exhibits higher mRNA-RBP occupancy in 
primed EpiSC limes PSCs (p=1.9E-08, two sided Welch’s t-test).  
 
 
 
Fig. 21. Functional annotations of dynamic and static RBPs and functional 
enrichment of proteome PTMs. (A-B) Analysis of the RBPs in the category that exhibits 
changes in the mRNA-RBP occupancy (A) or all RBPs (B).  GO terms analysis by gene 
ontology. 
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3.1.7 Signaling-induced RBP translocation 
 
Observing the changes in the mRNA-RBP occupancy during the 
transition from naive to epiblast pluripotency  (Fig. 21B) led me to postulate 
the direct involvement of signaling pathways in the regulation of cell states 
via modulation of RBP functions. This is because key developmental 
signaling pathways, including the MAP kinase cascade, activate the naïve-
>primed state transitions and lineage commitment. The classical view is that 
MAPK-ERK regulates gene expression by phosphorylation of transcription 
factors, however by analyzing functional enrichment of phosphopeptides 
between naïve and primed cell state I observed that dynamically 
phosphorylated are mainly RBPs (Fig. 21C). Combined this is a strong 
evidence to argue that MAPK-ERK also regulates RBPs (Fig. 21C), indicating 
that there is a tight link between signaling and post-transcriptional regulation. 
MAPK-ERK, for example, in diverse settings phosphorylates several 
heterogeneous ribonucleoproteins (hnRNP, Habelhah et al., 2001, Chang et 
al., 2007, Shimada et al., 2009, Reinhardt et al., 2010), leading to their 
cytoplasmic accumulation. Recently MAPK/ERK activation was also found to 
led to phosphorylation of LIN28A in ESCs, which increases its stability 
(Tsanov et al., 2017). 
 
Because I discovered differential mRNA-RBP occupancy of LIN28A 
comparing naive and primed states, I set to decipher how LIN28 
phosphorylation contributes to the observed increase in its mRNA binding. I 
first monitored changes of LIN28A locations during transitions of the 
pluripotency stages and early primitive streak differentiation.  To confirm the 
redistribution of LIN28A by a method that does not depend on antibody 
staining, I utilized the CRISPR/Cas9 system to recombine (HDR-targeting) a 
fluorescent gene into the endogenous locus of LIN28A and Lin28a in human 
and mouse PSCs (Fig 22). To generate fused LIN28A/lin28a-eGFP proteins 
without an intervening linker, I introduced the coding sequence of eGFP into 
the LIN28A/Lin28a open reading frame right before stop codon. This enables 
to analyze the location of endogenous LIN28A during the transitions of the 
pluripotency states. Importantly, I found that LIN28A localization is consistent 
in the respective stages of h/mPSCs; primed state human ESCs and mouse 
EpiSCs exhibit predominantly cytoplasmic LIN28A, while in naive-stage 
mouse ESCs, the protein is predominately present in the nucleus. 
Importantly, following hPSCs primitive streak differentiation, LIN28A is 
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extensively translocated to the nucleolus. Consistent, with antibody-mediated 
tracing of m/hLIN28A, the eGFP fused version also exhibited subnuclear 
compartmentalization that was observed with antibodies (Fig. 23).  
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Fig. 22. Generation of LIN28A-GFP fusion PSC l ines.  
(A) Schematic overview of eGFP insertion into the Lin28a/LIN28A locus via CRISPR/Cas 
assisted gene editing. Target site followed by PAM motif (5’-AGG) is located on the top 
strand (positive strand) upstream of LIN28A stop codon. Integration is facilitated by double 
strand breaks created by Cas9 directed to the target sequence by a specific gRNA. (B) 
.Screening PCRs of all CRIPSR generated Lin28a-eGFP fusion cell lines showing 2 distinct 
PCR products that are specific either for WT mPSC (lower band) or for Lin28a-eGFP fusion 
mPSCs. (C) Cells that express a functional Cas9 complex can then be identified by 
expression of GFP and enriched via FACS. Shown are the sorting of GFP-positive cells 
following Cas9 and LIN28A gRNA transfection (5 days post-nucleofection). (D) Western blot 
analysis of clone 1 and parental H9 cells using anti-LIN28A antibody demonstrating the 
presence of wild type LIN28A and a LIN28A-GFP fusion protein. One clone harbored 
replacement of both LIN28A alleles. 
 
Importantly, I found that LIN28A exhibit strong enrichment in nucleoli 
in the naïve PSCs. This was reported previously for the equivalent stage of 
mouse embryos where LIN28A is exclusively nucleolar in the ICM of early 
blastocysts (Vogt et al., 2012). Intriguingly, I found that LIN28A translocate to 
cytoplasm during the transition from naive to primed state, and upon 
formation of the epiblast (E5.5) in vivo (Fig 23A). 
 
Next, I hypothesized that the developmental translocation of LIN28A 
alters its biological function. To analyze this possibility, I analyzed 
interactions of the LIN28A with other proteins. For that I performed the Co-IP 
of LIN28A-GFP (using an anti-GFP antibody) and LC-MS/MS nuclear extracts 
of mesoderm derivatives of human ESCs (which exhibit nuclear LIN28A 
translocation). In total I detected 469 putative proteins enriched by a factor of 
6 or more over no-GFP control PSCs (Fig. 5B). Interactome bioinformatics 
showed that LIN28A interacting proteins include spliceosome components 
(e.g. U2AF65, SF3B and SF3A), the polyAdenylation machinery as well as 
other mRNA processing pathways (Fig. 23B). 
 
To understand the functional connection between these interacting 
RNAs and LIN28A, I next conducted iCLIP using an anti-GFP antibody for 
immunoprecipitating the LIN28A-eGFP fusion protein. I found that in 
mesoderm derivatives of human ESCs, nuclear LIN28A accumulation 
correlates with binding at intron-exon boundaries, including enrichment 3’ to 
splice sites, and immediately downstream to the intron branch point (Fig. 
23C), a pattern that overlaps with U2AF65 binding. Because U2AF65 binds 
to polypyrimidine tract at 3' splice sites, often acting as a repressor of 
splicing, I hypothesize that LIN28A recruitment to these sites serve a similar 
function (Fig 23C). In additional we know that other factors that bind near 
branch point often lead to silencing effects (Witten and Ule, 2011). 
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Furthermore, because I identified U2 snRNP protein components as putative 
interactors of LIN28A, this indicates that LIN28A may be recruited to these 
sites by U2 snRNP and we show enrichment of TDP-43 binding sites at the 
intron-exon boundaries (Fig 23D-E). Taken together this provides a novel 
direction to understand nuclear LIN28A role in cell fate decisions. 
 
 
 
Fig 23: LIN28A redistr ibution and novel nuclear functions 
(A) LIN28A and LIN28A-eGFP (mouse and human, respectively) exhibit naïve and primed 
pluripotency-dependent distribution in vitro and in mouse embryos. Note that LIN28A 
localization shifts from nuclear (primarily nucleoliar) to cytoplasm upon PSC priming. Mouse 
blastocyst Lin28a localization taken from (Vogt et al., 2012). Inset shows CRISPR/Cas9 
generated LIN28-GFP biallelic fusion protein expressed in human and mouse PSCs, 
respectively. (B) LIN28A nuclear interactome includes categories of majority of the RNA 
processing pathways engaged in nucleus. Specifically  enriched are polyadenylation factors 
and components of the U2 snRNP multi-protein spliceosomal complex. (C-D). RNA maps of 
LIN28A cross-linked sites of regulated pre-mRNAs. (C). Positions of cross-linked nucleotides 
were plotted for intron-exon boundaries of alternatively utilized exons (C), and surrounding 
the branch point sequence (D, E). An example of LIN28A binding sites in the mesoderm-
inducer β-catenin, reveals intronic binding adjacent to 3’splice site, indicating potential 
involvement in β-catenin alternative splicing. 
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3.2 CROSS-REGULATION BETWEEN TDP-43 AND PARASPECKLES 
PROMOTES PLURIPOTENCY- DIFFERENTIATION TRANSITION 
 
What mechanisms govern and maintain cell states during the process 
of differentiation is a pivotal question in science. Alternative polyadenylation 
(APA) is a process that diversifies the 3’ end of mRNAs and such that 
appears to be closely related to cell state. Changes of polyadenylation 
patterns have been observed upon mouse myogenesis of C2C12 cells (Ji et 
al., 2009) and adipogenesis in 3T3-L1 cells  (Hoque et al., 2013). However, it 
is not clear whether the APA landscape is modulated upon exit of 
pluripotency, how and if APA contributes to the dismantling of pluripotency 
and which factors regulate APA during this transition. 
 
3.2.1 Alternative polyadenylation landscape in early PSC 
differentiation 
 
To study the APA regulatory program, I differentiated mouse and 
human PSCs into precursors of the embryonic layers called mesoderm 
progenitors. I used mouse embryonic stem (ES) cell line bearing an insertion 
of GFP into the T(Brachyury) locus (Bra::eGFP), and sorted the eGFP+ 
population following 72hrs of Wnt3a and Activin A treatment, which is a 
condition known to promote differentiation of primitive streak cells that mimic 
nascent mesoderm (Kurek et al., 2015) (Fig. 24a). To confirm this embryonic 
commitment, I compared the gene cohorts in the treated cells to 
undifferentiated PSCs. This comparison is based on the Quant-Seq 
technique, which characterizes the PolyA sites of mRNAs and can be used 
for quantitative gene expression measurements (Fig. 24a). Similarly, I derived 
a population of human primitive streak-like progenitors by exposing human 
PSCs to Wnt signaling for 72 hrs using a small-molecule inhibitor of GSK3b 
(CHIR99021) according to a published protocol (Blauwkamp et al., 2012). 
RNA sequencing and analysis of the differentially expressed genes with 
respect to undifferentiated cells confirmed the lineage restriction of early 
primitive streak progenitors (Fig. 24b). 
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Fig 24. Differentiat ion of mouse and human PSCs into primit ive streak 
precursors.  
(A) representative scatter plot showing transcripts detected by RNA-Seq in PS-like 72hrs 
progenitors and undifferentiated mouse (A) and human (B) PSCs. Differentially expressed 
genes with adjusted p-value < 1e-5 and < 1e-20 (Fisher’s exact test, false discovery rate 1e-
15) are labeled red (n=2/condition) in mouse and human comparison, respectively. 
 
Next in collaboration with Gregor Rot, we used the computational 
integrative web platform called apaExpress (Rot et al., 2017), to analyze the 
locations of PASs (Fig 25A) and total number of PASs extracted from the 
Quant Seq data in h/mPSCs and PS progenitors (Fig. 25B). We validated the 
identification of PASs by examining the overlap with a published PAS dataset 
(Derti et al., 2012) (Fig. 25C), by analyzing the efficiency of cleavage (Fig. 
25D), and by comparing the nucleotide composition of newly identified PASs 
(Fig. 25E) with known PASs (Fig. 25F). 
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Fig 25: Global analysis of polyA sites.  
(A) Quantitative analysis of PAS positions in undifferentiated hESCs and PS progenitors that 
includes lengthened and shortened 3’ UTRs. Significant changes (adjusted p-value <0.001, 
Fisher’s exact test) are colored red (n=4/condition). (B) The number of PASs per gene 
detected by global 3’RNA-Seq in hESCs and PS progenitors. (C) The PAS positions 
comparing PASs detected in hESCs and PS progenitors versus PASs identified in HEK293 
cells (1). (D) Locations of PASs detected in hESCs and PS progenitors versus predicted 
PASs (PAS-strong, PAS-weak and PAS-less, based on the presence of poly(A) signals) 
classified using polyAR (2). (E-F) The nucleotide composition around newly identified PASs 
in hESCs and PS progenitors (E), or PASs that overlapped with those of Derti et al., (1) (F). 
The close homology supports the bona fide classification of novel PASs in this study. 
 
To identify mechanisms that regulate the APA events observed during 
PS differentiation, I analyzed sequence motifs that are enriched close to the 
PASs in undifferentiated hESCs versus PS progenitors. We noted that GUG 
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was the most significantly enriched motif in the region upstream of the 
poly(A) signal of the regulated PASs, where accessory regulatory sites 
typically reside (Di Giammartino et al., 2011) (Fig. 9A). As TDP-43, an 
important regulator of alternative splicing, binds to such motifs (Lukavsky et 
al., 2013; Tollervey et al., 2011b), I next assessed if it underlies the regulation 
of APA during hESC differentiation. 
 
Fig. 26. Analysis of sequence motifs enriched around differentiat ion- and TDP-
43-regulated PASs. (A) The sequence motifs that are most significantly correlated with 
the enriched PASs in hESCs compared with PS progenitors, hESCs compared to shTDP-43 
KD (B), and in mESCs compared with KO of Tdp-43 (C). 
 
We found that the knockdown (KD) of TDP-43 in undifferentiated 
hESCs also gives rise to a significant enrichment of the GUG motif in the 
region upstream of the poly(A) signal of the regulated PASs (Fig. 26B) and 
similar enrichment was observed also by inducing a knockout (KO) of Tdp-43 
in mouse ESCs (mESCs) (Fig 26C), indicating evolutionary conserved role 
TDP-43 in regulation of APA.  
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3.2.2 TDP-43 regulated developmental alternative 
polyadenylation 
 
Strikingly, nearly two thirds of the differentiation-induced APA events 
took place in the same genes and the same direction as following TDP-43 KD 
(Fig. 27A), and were highly correlated (Fig. 27B) (R=0.62, Pearson 
correlation, p-value < 2.2e-16, Fig. 27A). In contrast, we observed no 
correlation in transcript abundance between PS progenitors and TDP-43 
depleted cells (Fig 27C), indicating that TDP-43 regulates only APA but not 
transcriptional changes during differentiation of primitive streak progenitors. 
Finally, we found that the level of TDP-43 protein decreases upon PS 
differentiation (Fig. 27D-E). Taken together, this indicates that the expression 
of TDP-43 promotes global PAS rearrangement in ESCs. 
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Fig 27: TDP-43 does not directly regulates levels of genes exhibit ing APA 
upon differentiat ion.  
(A) scaterplot indicating differentially polyadenylated genes that are also regulated by TDP-
43 (red) or are not TDP-43 dependent (grey) (B) A scatterplot showing the direction of APA, 
with preference for proximal (positive values) or distal PASs (negative values) upon PS 
progenitor differentiation of hESCs and shTDP-43 KD versus control shRNA. Linear 
regression (grey line) and the 90% confidence interval region (light blue) are shown 
(Pearson’s correlation coefficient, R=0.62). Threshold set for TDP-43 regulated PASs is p-
value < 0.05. (C) A scatterplot of associations in transcript level changes upon TDP-43 KD 
relative to undifferentiated hESCs, and in PS progenitors relative to undifferentiated cells. 
Limited to TDP-43 APA to genes exhibiting APA following TDP-43 KD (n=2 / category). (D) A 
Western blot of TDP-43 and Histone H3 using samples obtained in hESCs and upon 48hrs of 
directed differentiation towards mesoderm, trophoblast, neuroectoderm progenitors using 
CHIR99021, BMP4, retinoic acid (RA) treatment, respectively. (E) A combined plot showing 
changes in expression of OCT4, SOX2 and TDP-43 mRNAs and TDP-43 protein after 24hrs 
of CHIR99021 treatment compared to undifferentiated hESCs. 
 
Congruently with the prevalent direction of APA in Zebrafish 
gastrulation (Li et al., 2012), we observed also a general trend of transcript 
lengthening of transcripts in the transition from pluripotency to PS progenitors 
(Fig. 28A). Similar transcript lengthening was observed also upon TDP-43 
knockdown (Fig 28A-B). 
 
 
Fig 28: alternative polyadenylation landscape changes upon human PSC 
differentiat ion and TDP-43 KD.  
(A) A histogram depicting the direction and degree of APA during PS differentiation and 
following TDP-43 KD in human ESCs. (B) A representative Western blot analysis of TDP-43 
shRNA-transduced hESCs and cells treated with control shRNAs. Histone H3 is used as a 
loading control. 
 
To decipher if TDP-43 directly regulates APA during early 
differentiation, we analyzed the RNA-binding profile of TDP-43 in hESCs by 
individual-nucleotide resolution crosslinking and immunoprecipitation (iCLIP) 
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(Tollervey et al., 2011b) (Fig. 29A). We assessed the enrichment of 
pentamers within 50 nucleotides surrounding crosslink sites. iCLIP revealed 
that the most significantly enriched pentamers are GUGUG and UGUGU (Fig 
29B). Analysis of the RNAs bound by TDP-43 showed that 7,5% of all 
crosslinked sites are located in 3′UTRs (Fig 27C). I therefore reasoned that 
TDP-43 has an important role in direct regulation of APA. 
 
 
Fig. 29. TDP-43 iCLIP PSCs  
(A) An autoradiograph of 32P-labelled RNAs in the presence or absence of UV crosslinking 
and an anti-TDP-43 antibody in mESC (left) and hESC (right). High and low concentrations of 
RNase were used to confirm the presence of RNA bound to TDP-43. The asterisk marks the 
position in the gel correspond- ing to the size of a TDP-43 monomer. (B) A representative 
TDP-43 Western analysis of mESC extracts before and after crosslinking and TDP-43 
immunoprecipitation. (C) A pie chart depicting the regional distribution of TDP-43 binding 
sites identified by TDP-43 iCLIP in mESCs. (D) Z-scores of pentamer occurrences 
surrounding (−30 nt to +30 nt) all TDP-43 cross-linked sites in hESCs as determined by 
iCLIP. The sequences of the two most enriched pentamers are depicted. The Pearson’s 
correlation coefficient between the two shown samples is R=0.91. (E) Z-scores of pentamer 
occurrences surrounding (−30 nt to +30 nt) all TDP-43 cross-linked sites in mESCs as 
determined by iCLIP, using either TDP-43 antibody targeting the endogenous protein (x-
axis) or using antibody targeting GFP of the overexpressed TDP43-GFP (y-axis). The 
sequences of the two most enriched pentamers are depicted.  
 
We further plotted TDP-43 binding sites detected by iCLIP around 
genomic locations of alternatively polyadenylated mRNAs and marked the 
polyA site at the center of the RNA maps by a red line (Fig. 30A). The 
approach for visualizing an RNA map of APA is analogous to any other 
region of interest, such as for instance the intron-exon boundaries in the 
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context of alternative splicing (Ule et al., 2006). An RNA map of summarized 
TDP-43 crosslinking, or of GU-rich motifs, around the PASs that undergo APA 
following TDP-43 KD, suggests position dependent dual role of TDP-43 in 
regulating APA. The RNA map detects enriched TDP-43 binding in the 25-
100 nucleotide (nt) region upstream of the PASs that are repressed by TDP-
43, and to a lesser extent further than 100nt upstream and downstream of the 
PASs that are enhanced by TDP-43 (Fig. 30A). This indicates that TDP-43 
regulation of APA is position-dependent, exhibiting a repressive effect on 
polyadenylation when TDP-43 binds close to a PAS, and conversely, an 
enhancing effect on APA when TDP-43 binds further away from a PAS (Fig. 
30B-C). By inducing a KO of Tdp-43 in mouse ESCs (mESCs) we noted that 
the dual regulatory role of TDP-43 is evolutionary conserved (Fig. 30D). 
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Fig. 30. TDP-43 is a conserved posit ion-dependent regulator of APA. *  
(A) An “RNA map” showing the positions of TDP-43 crosslinking (top) or GU-rich motifs 
(bottom) summarized across all the APA sites comparing scrambled shRNA control hESCs 
(n=4) with TDP-43 KD (n=8). Crosslinking at the PAS that are enhanced by TDP-43 (89) is 
shown in red, at the repressed PAS in blue (119), and at the unchanged PASs (893) in black 
lines. (B-C) Representative diagrams of UBN2 (B) and GHITM (C) 3’ UTRs showing cross-
linked positions of TDP-43 in undifferentiated hESCs (top, black bars), and two alternative 
mRNA isoforms as determined by 3’RNA-Seq (bottom). The TDP-43 KD effect in hESCs 
(green) indicates that TDP-43 represses the proximal cleavage site of UBN2, and 
conversely, enhances the use of the proximal PAS of GHITM. The same trends were noted in 
human ESC-derived PS progenitors (red). (D) An “RNA map” showing the positions of TDP-
43 crosslinking (top) or GU-rich motifs (bottom) summarized across all the APA sites 
comparing scrambled shRNA control mESCs (n=4) with Tdp-43 KO (untreated samples 
N=12, and tamoxifen-induced samples N=10). Crosslinking at the PAS that are enhanced by 
TDP-43 (316) is shown in red, at the repressed PAS in blue (127), and at the unchanged 
PASs (1616) in black lines.   
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3.2.3 Alternative polyadenylation of pluripotency circuitry mRNAs 
 
To understand whether the regulated APA events contribute to the exit 
from pluripotency, I focused on the conserved targets of mouse and human 
TDP-43. I identified 523 such common targets (38% of the human 
compendium) in h/mESCs by shRNA KD and conditional KO, respectively. 
This includes the h/m pluripotency core factor SOX2/Sox2 transcript, which 
undergoes a 10-fold lengthening of its 3’ UTR upon TDP-43 KD and hESC 
differentiation (Fig. 31A). Importantly, I found that the TDP-43 crosslinking 
pattern and the APA direction of Sox2 are consistent with the modes of TDP-
43 regulation indicated by the RNA map (Fig. 30): TDP-43 binds close to the 
repressed distal PAS and far from the enhanced proximal PAS (Fig. 31B), 
indicating bimodal regulation, respectively. The functional link between TDP-
43 and Sox2 is supported by further findings including Sox2 transcript and 
protein down-regulation upon conditional KO of Tdp-43 in mESCs (Fig. 31C), 
which also promotes accelerated differentiation, as evident by the loss of the 
dome-shaped compact colony morphology (Fig. 31D). 
 
 
Fig. 31: TDP-43 regulates SOX2 via APA.  
(A) Representative diagrams showing the relative frequencies of the PASs in Sox2/SOX2 
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and the 3’ mRNA isoforms (mESCs FPKM levels in brackets; n=3) upon tamoxifen-induced 
Tdp-43 KO in mESCs (iTDPKO, fig. S5D-F), and TDP-43 KD, 72hrs of PS differentiation by 
CHIR99021 treatment, and control human ESCs. (B) Representative TDP-43-binding 
clusters (analyzed by iCLIP, Fig. S4) surrounding the proximal and distal PASs of Sox2. (C) 
A Western blot analysis of SOX2 levels in iTDPKO mESCs: control cells and following 
tamoxifen treatment to induce KO and 48hrs of spontaneous differentiation. (D) 
Representative photomicrographs of iTDPKO mESCs maintained in naive media, treated 
with FBS to induce initial differentiation, or following tamoxifen treatment in naive mESCs 
media 48hrs.  
 
To further study the effect of TDP-43 on SOX2 expression, we used a 
minigene reporter containing the 3’ UTR of SOX2 located downstream of the 
eGFP coding sequence (Fig. 32A). Flow-cytometry confirmed that TDP-43 
overexpression in HEK 293T cells increases the GFP signal (Fig. 32B). This 
indicates that TDP-43 enhances the pluripotency circuitry through conserved 
direct regulation of PAS choice in SOX2 mRNA, which is required for efficient 
translation. To show that APA switch governs GFP expression via regulation 
of the 3’UTR of SOX2, I mutated the proximal PAS. This reverted the effect of 
TDP-43 (Fig. 32C). Next, I speculated that the mechanism governing down-
regulation of the long SOX2 3’UTR isoform is mediated by microRNAs, 
because I conduced Targetscan analysis (Lewis et al., 2005), which showed 
a putative miR-21 target site in the long isoform. Consistent with this 
hypothesis is the observation that miR-21 is upregulated in exit of 
pluripotency (Singh et al., 2015). I therefore mutated the miR-21 binding site 
in the reporter construct, and found that this leads to a loss of response to 
TDP-43 overexpression (Fig. 32D). This indicates that TDP-43 decrease upon 
early differentiation causes SOX2 mRNA lengthening, which coincides with 
miR-21 increase (Singh et al., 2015), leading to a decrease in SOX2 
transcript. Taken together, this confirms that TDP-43 is a conserved direct 
regulator of global APA patterns safeguarding pluripotency circuitry. 
 
Fig 32: TDP-43 coordinates translat ional regulation of Sox2 through APA.  
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(A) A scheme of the eGFP-SOX2 3’ UTR reporter minigene showing the positions of the 
proximal and distal PASs and of the miR-21 binding site. (B-D) Representative flow 
cytometry analyses of HEK293T cells harboring a doxycycline inducible cassette of TDP-43 
(Budini et al., 2015) transfected with miR-21 and the respective GFP-SOX2 3’ UTR 
constructs: unmodified (B), with deletion of the proximal PAS (C) or with deletion of the miR-
21 binding site (D) in the presence or absence of doxycycline.  
 
GO-term analysis of the APA transcripts that are regulated by TDP-43 
in h/mESCs demonstrates that this factor regulates primarily genes 
implicated in post-transcriptional processes (Fig. 33). Consistent with this are 
findings that post-transcriptional regulation governs the production of the 
long non-coding RNA (lncRNA) NEAT1, which serves as a hub for formation 
of paraspeckels, and that undifferentiated h/hESCs lack paraspeckles. 
Because NEAT1 has two isoforms, short polyadenylated and long non-
polyadenylated, coined respectively, v1 and v2, and only the latter isoform 
serves as the scaffold paraspeckles (Naganuma et al., 2012). The decrease 
of TDP-43 expression level upon dissolution of pluripotency coincides with 
the NEAT1 isoform switch. Thus, I hypothesized that TDP-43 regulates the 
formation of paraspeckles upon exit from pluripotency. Furthermore, because 
TDP-43 has been shown to localize to paraspeckles, I speculated that these 
nuclear domains that are thought to coordinate post-transcriptional 
processes by association with RBPs (Naganuma et al., 2012; Nishimoto et 
al., 2013; West et al., 2016), contribute to a TDP-43 down-regulation during 
exit from pluripotency. 
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Fig. 33. TDP-43 preferential ly regulates APA of genes involved in post-
transcriptional processes, and in particular other RBPs that are involved in 3’end mRNA 
processing, both in (A) hESCs and (B) mESCs. p-values are given in tissue categories. GO 
terms analysis by gene ontology.  
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3.2.4 TDP-43 governs formation of paraspeckles upon exit of 
pluripotency 
 
Paraspeckles have been reported to exist in various cell types with the 
exception of ESCs (Chen and Carmichael, 2009), but the mechanisms 
controlling paraspeckles formation in differentiation have not been 
discovered. It has been reported that one of the RNAs with most abundant 
TDP-43 binding is NEAT1 (Tollervey et al., 2011b). By analyzing the TDP-43 
iCLIP of h/mNEAT1 I found that TDP-43 binds to a vertebrate-conserved 
cluster of UG-rich motifs, present 100-200 nt upstream of the PAS that 
produces the short Neat1v1 isoform (Fig. 34A). According to the pattern 
defined by the RNA map (Fig. 30, 34B), such distal binding pattern suggests 
that TDP-43 enhances the production of Neat1v1 in ESCs, thereby 
preventing paraspeckles polymerization in these cells. In accordance to this 
prediction, I found that KO of Tdp-43 in mESCs leads to expression of 
Neat1v2 (Fig. 34C), and formation of paraspeckles even in undifferentiated 
mESCs (Fig. 34D-E; 8-fold increase, x2 test, p< 6e10-6). Conversely, 
overexpression of Tdp-43-eGFP fusion protein in mESCs following 72hrs of 
spontaneous differentiation prevents the formation of paraspeckles (Fig. 
34F). 
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Fig. 34. TDP-43 regulates paraspeckle formation through a conserved PAS 
choice mechanism.  
(A) Cross-linked positions (red) of TDP-43 in mESCs (n=8) plotted on a diagram of Neat1v1 
and v2 isoforms. Blue bars correspond to regions of high sequence conservation among 
vertebrates. (B) A close-up of the area upstream of Neat1v1 PAS, highlighting the GU-rich 
motifs that correspond to the TDP-43-bound sites. (C) Representative RNA-Seq data 
showing Neat1 mapped reads following tamoxifen induced KO of Tdp-43 and of untreated 
control cells (iTDPKO line, fig. S5D). (D) Representative maximum projection 
photomicrographs of Neat1v1 and v2 isoforms analyzed by single molecule fluorescent in 
situ hybridization (smFISH, fig. S7). Red: Neat1v1 and v2 probes; blue: DAPI. (E) 
Quantification of paraspeckles (number of Neat1v1 and v2 foci/cell) in mESCs 72hrs 
following induction of KO of Tdp-43 by tamoxifen treatment and in untreated mESCs. (F) 
Paraspeckle count in control mESCs, 72hrs following induction of KO by tamoxifen, in 
spontaneously differentiated mESCs by 72hrs FBS treatment, and in differentiated cells that 
were prepared by the same treatment with the overexpression of Tdp-43-GFP. >200 cells 
were analyzed per group in E-F. T-test, p<0.001. 
 
To confirm evolutionary conserved action of TDP-43 in regulating 
paraspeckles via APA, I repeated the experiments in human ESCs. This 
confirmed that hESC don’t efficiently form paraspeckles (Fig 35A-B), while 
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TDP-43 KD lead to expression of Neat1v2 and paraspeckles even in 
undifferentiated cells (Fig 35A-B). I thus concluded that TDP-43 maintains the 
production of NEAT1v1 in ESCs, and that the decrease of TDP-43 upon 
differentiation stimulates the production of Neat1v2 and consequently the 
formation of paraspeckles. 
 
 
Fig 35: TDP-43 regulates paraspeckle formation in hESCs. *   
(A) Representative maximum projection photomicrographs of NEAT1v1 and v2 isoforms 
(red) in spontaneously differentiated hESCs treated for 72 hrs with a medium supplemented 
with knockout serum replacement (KSR) without bFGF, comparing control and cells following 
TDP-43 KD. Blue: DAPI. (B) Quantification of the frequency of cells exhibiting paraspeckle 
foci in A; ~100 cells analyzed per group.  
 
The nature of the stimuli that induce the formation of paraspeckles 
during ESC differentiation are unknown, as is the timing of this and the 
lineage direction in which it takes place. To address these questions I 
conducted RNA-Seq and counted paraspeckles in hESCs prompted to 
differentiate to diverse fates. I found that NEAT1 is amongst the 18 up-
regulated transcripts that are common to 24hrs treatment by purified Wnt3a 
protein, a small-molecule inhibitor of GSK3α/β, or BMP4 (Fig. 36A). 
Furthermore, the paraspeckle frequency and kinetics in early trophoblast, 
neuroectoderm, and mesendoderm hESC progeny was similar (Fig. 36B-D).  
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Fig 36: Kinetics of paraspeckle formation in early hESC differentiat ion.  
(A) A Venn diagram depicting differentially expressed transcripts in hESCs exposed to the 
indicated differentiation stimuli for 24hrs relative to untreated cells (n=2 per condition). (B) 
Paraspeckle count in hESCs as a function of the differentiation treatment, 72hrs BMP4, 
CHIR99021 and retinoic acid (RA), promoting trophoblast, mesendoderm and neuroec- 
toderm, fates, respectively, and in control untreated cells (~250 cells analyzed per group, t-
test, p<0.001). (C) Representative maximum projection microphotographs of differentiation-
stimulated hESCs (conditions as in H, 72hrs). Red: NEAT1v2 probe; blue: DAPI. 
 
Next, I analyzed whether the production of NEAT1 is post-
transcriptionally regulated in ESCs. I first generated CRISPR-Cas9 modified 
h/mESCs harboring targeted deletions of regulatory regions surrounding the 
proximal PAS of Neat1/NEAT1 (Fig. 37A-C), and confirmed that both h/m 
NEAT1ΔPAS and Neat1ΔPAS ESC lines efficiently transcribe the full length 
v2 (Fig. 37D-E) and form paraspeckles already in pluripotency conditions I 
mouse and human ESCs. I found that deletion of internal poly(A) site within 
NEAT1/Neat1 leads to a similar effect on NEAT1 processing as TDP-43 
depletion (Fig. 37F-I). I therefore concluded that the production of the long 
NEAT1v2 isoform is inhibited if the internal polyadenylation site (polyA-site) 
within NEAT1 pre-mRNA is used, which produces the short NEAT1v1 
isoform.  
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Fig 37: CRISPR/Cas9 deletion of internal poly(A) site of Neat1/NEAT1  in 
mouse and human PSCs. 
(A) Schematic overview of CRISPR-Cas9 generation of paraspeckles-forming full length 
Neat1/NEAT1ΔPAS m/hESCs  (B-C) Gel electrophoresis of creening PCRs confirming 
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deletions of internal pA site in mouse (B) and human (C) Neat1/NEAT1ΔpA  generated ESC 
lines. (D-E) RT-qPCR quantification of Neat1/NEAT1 v1 and v2 in Neat1/NEAT1ΔpA and 
parental mouse (D) and human (E) ESCs.  (F-I) Representative maximum projection 
photomicrographs of Neat1v1/v2 (F) and of NEAT1v1/v2 (H) isoforms analyzed by single 
molecule fluorescent in situ hybridization (smFISH) quantified in single cells (G and I, 
respectively). (F-H) Undifferentiated mESCs, Neat1ΔpA mESCs, and mESCs 72 hr following 
induction of Tdp-43 KO by tamoxifen treatment (iTDPKO). (H-I) Undifferentiated hESCs, 
NEAT1ΔpA hESCs, and hESCs following siTDP-43 mediated KD (>200 cells were analyzed 
per group). Red: Neat1/NEAT1v1 and v2 probes; blue: DAPI.  
 
To confirm that NEAT1 is post-transcriptionally repressed in pluripotent 
stage I analyzed the nascent RNAs in hESCs using pulse labeling and 
sequencing (Michel et al., 2016). While NEAT1v1 was not detected in total 
RNA-Seq, it is detected by the nascent RNA-Seq, indicating that this isoform 
has a short half-life in hESCs (Fig. 38A). This confirms that NEAT1 is 
transcribed in PSCs, but is post-transcriptionally repressed and explains why 
paraspeckles are absent from undifferentiated PSCs. Furthermore, I analyzed 
the intranuclear localization of NEAT1 using a subcellular fractionation 
protocol that enables discrimination of nascent chromatin-associated RNAs 
from free nucleoplasmic RNAs. By applying this protocol in conjunction to 
RNA-Seq, I confirmed that NEATv2 is chromatin-bound (Mao et al., 2011) as 
opposed to NEAT1v1 which is enriched in the nucleoplasm (Fig. 38). I 
conclude that the expression of TDP-43 in ESCs maintains production of the 
unstable NEAT1v1 isoform, and its decrease upon early differentiation 
underlies an isoform switch to chromatin bound stable NEAT1v2 and 
formation of paraspeckles. 
 
Fig 38: NEAT1 isoforms and intra-nuclear localization.  
Representative outlines of NEAT1 RNA-Seq mapped reads in the ~20kb gene locus; the two 
isoforms are indicated. The samples are undifferentiated and 24hrs CHIR99021-treated 
hESCs, nascent RNA of undifferentiated hESCs, hESCs 48hrs following KD of TDP-43 and 
chromatin- and nucleoplasm-enriched fractions from 48hrs BMP4-treated hESCs, all as 
indicated. 
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3.2.5  Composition of paraspeckles 
 
The cellular functions of paraspeckles have yet to be clarified. To 
assess if in a developmental context paraspeckles can modulate post-
transcriptional processing by relocating RBPs from their other binding sites in 
mRNAs, I conducted mRNA-RBP occupancy analysis, coined RBPome, to 
assess how induction of paraspeckles influences binding of RBPs to their 
mRNA binding sites by using the global mRNA-RBP occupancy 
analysis(Castello et al., 2012) (Fig. 39).  
 
Fig. 39: Schematic overview of NEAT1-RBPome strategy.  
This approach uncovers mRNA binding rearrangements of RBPs via paraspeckle 
associations. 
 
For that I compared the mRBPome of NEAT1Δ1APo hESCs and 
control cells. While the total abundance of RBPs in the mRNA-RBP 
occupancy assay remained unaltered (Fig. 40A), the induction of NEAT1v2 in 
NEAT1ΔpA cells led to decreased mRNA-RBP occupancy of known 
paraspeckle proteins, including NONO, SFPQ and TDP-43, but not of CPEB1 
which does not localizes to paraspeckles (Fig. 40C). In addition by coupling 
RBPome to LC-MS, we noticed that the mRNA occupancy of TDP-43, which 
has been shown to localize to paraspeckles (Naganuma and Hirose, 2013; 
West et al., 2016),  was reduced to a similar extent as NONO/SFPQ, which is 
of additional interest since NEAT1 is one of the top RNA targets of TDP-43 in 
somatic cells (Tollervey et al., 2011b). This indicates that NEAT1v2 has a 
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capacity to relocalize a significant portion of TDP-43 from mRNAs, which 
likely influences its regulatory activity. 
 
Fig. 40: Paraspeckle-mediated depletion of RBPs.  
(A-B) A gel migration assay of covalent RNP complexes (Fig. 39) treated (A) or undigested 
(B) with RNase I. The specific pulldown of RNP complexes is confirmed because proteins 
migration is apparent only following RNase I treatment, while undigested RNPs bound to 
mRNAs remain in gel pockets. (C) Western blot analysis of TDP-43, NONO and SFPQ using 
crosslinked (UV-C irradiated) whole cell lysates derived from control and NEAT1ΔpPAS 
human ESCs. H3 serves as loading controls. (D) A Volcano plot exhibiting changes in RBP 
occupancy in the presence of NEAT1v2 in undifferentiated hESCs. Annotated paraspeckles 
proteins are labeled red. 
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3.2.6 Feedback cross-regulation between TDP-43 and 
paraspeckles governs PSC differentiation and 
reprogramming 
 
In order to understand how the mutual regulation between 
paraspeckles and TDP-43 may promote distinct cellular identities in the 
interface of pluripotency and termination of this state, I analyzed their 
respective effects on somatic cell reprogramming and differentiation kinetics. 
I first compared the differentiation kinetics of induced pluripotent stem cells 
(iPSCs) derived from Neat1-deficient mouse embryonic fibroblasts 
(Nakagawa et al., 2011) and control wt cells. Importantly, in spontaneous 
differentiation conditions the Neat1-/- miPSCs retain the stereotypical PSC 
colony morphology and expression of the pluripotency cell surface marker 
SSEA-1 for a longer time compared to control hPSCs (Fig 41A-B). Moreover, 
Neat1-/- miPSCs display delayed expression of the early differentiation 
marker SSEA-4 (Fig. 41C), meaning that pluripotency exit is slower in the 
absence of full length Neat1. Surprisingly we didn’t observe an overt effect 
on key pluripotency factors, albeit the levels of TGF-β superfamily core 
factors Lefty1 and Gdf3, but not of other canonical pluripotency factors in 
Neat1-/- cells were higher compared to control wt mESCs (Fig. 41C-F). In 
accordance, expression of Lefty1 is retained in 72hrs spontaneously 
differentiated Neat1-/- miPSCs (Fig. 41G). As expected (Kim et al., 2014), loss 
of LEFTY1 coincides with higher SMAD2 phosphorylation (Fig 41H), which 
promotes mesendoderm differentiation potential without influencing the self-
renewal of PSCs (Lee et al., 2011). This indicates that paraspeckle formation 
poises exit from pluripotency by antagonizing nodal signaling through 
phosphorylation of SMAD proteins.  
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Fig 41: Paraspeckles poise PSC differentiat ion.  
(A) Representative photomicrographs of 36hr Neat1-/- and control wt miPSCs treated with 
spontaneous differentiation medium (+FBS -LIF). (B-C) Representative flow-cytometry 
analyses of 48hr Neat1-/- and control wt miPSCs stained with SSEA-1 (B) or SSEA-4 (C), 
culture conditions as in (A). (D-E) Representative scatter plots showing transcripts detected 
by RNA-Seq in NEAT1/Neat1ΔpA h/mESCs (mESC= 2iLIF, hESCs=mTeSR; see methods; 
n=3/condition). Differentially expressed human genes with adjusted p-value < 1e-5 (Fishers 
exact test, false discovery rate <0.001) in (D), and mouse genes with adjusted p-value < 1e-
3 (Fishers exact test, false discovery rate <0.05) in (E) are labeled red. (F) RNA-Seq 
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observed changes of transcripts in Neat1/NEAT1ΔpA ESCs compared to undifferentiated 
m/hESCs. Differentially expressed genes are labeled red in mESCs and blue in hESCs (n=4 
per condition). (G) RNA-Seq observed changes of transcripts in Neat1-/- KO miPSCs 
compared to isogenic control cells (n=2 per condition), both upon 3days of spontaneous 
differentiation. (H) A Western blot of pSMAD2, SMAD2, GDF3 and Histone H3 in Neat1ΔpA 
mESCs and control cells supports the notion that paraspeckles antagonize 
TGFbeta/activin/nodal signaling. 
 
Next, we analyzed the role of TDP-43 in the context of reprogramming 
using human secondary fibroblasts harboring a doxycycline-inducible OKSM 
(OCT4, KLF4, SOX2, C-MYC) gene cassette (Cacchiarelli et al., 2015) (Fig. 
42A). We found that overexpression of TDP-43 results in a nearly twofold 
increase in the number of colonies expressing the pluripotency marker 
alkaline phosphatase (AP) and TRA1-60 (Fig. 42B-D), and confirmed that the 
resulting colonies had a stereotypical human induced pluripotent stem cell 
(hiPSC) morphology. In accordance, we noted a threefold increase in the 
number of cells expressing the pluripotency marker TRA-1-60 (Fig. 42E), and 
that >90% of the cells overexpressing TDP-43 expressed endogenous OCT4 
at an earlier reprogramming stage compared to control cells (Fig. 42F).  
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Fig. 42. TDP-43 
enhances somatic 
cell  reprogramming. 
(A) A schematic 
representation of the 
reprogramming strategy 
that relies on hiF-T 
secondary fibroblasts 
harboring inducible 
reprogramming factors 
(iOKMS) controlled by 
the reverse doxycycline 
transactivator. (B-C) 
Analysis of the number 
of AP-positive nascent 
hiPSC colonies, at days 
10 (B) and 14 (C) of 
reprogramming (with 
total 24 technical 
replicates per 
condition). (D) AP 
staining of 
representative hiF-T 
reprogrammed cultures. 
TDP-43 overexpression 
as indicated, control - 
empty vector. (E) 
Representative flow 
cytometry analysis 
using Tra-1-60 of HiF-T 
cells at reprogramming 
day 21 (n=3). (F) A 
representative flow 
cytometry analysis of 
OCT4-GFP reporter on 
day 4 following 
doxycycline treatment 
of HiF-T fibroblasts. 
 
 
 
 
To validate the role of TDP-43 in promotion of the pluripotent state, we 
transiently overexpressed TDP-43 during the initial phase of reprogramming 
of primary adult human fibroblasts (Fig. 43A), and found that this leads to a 
5-fold increase in the number of iPSC colonies (Fig. 43B). Moreover inducible 
overexpression of Tdp-43 in mESCs, which inhibits paraspeckle formation 
upon differentiation (Fig. 34F), leads to an effect of delay in differentiation 
(Fig. 43C) that is similar to the KO of Neat1 (Fig 41C). Taken together, we 
find that the mutual negative feedback between paraspeckles and TDP-43 
promotes distinct cellular identities; paraspeckles promote differentiation, 
while TDP-43 inhibits differentiation and lowers the barrier to somatic cell 
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reprogramming. 
 
Fig. 43. TDP-43 enhances somatic cell  reprogramming and delays 
differentiat ion of PSCs: (A). A schematic representation of the reprogramming strategy 
for primary fibroblasts transfected with the OKMS 4-in-1 episomal vector (Diecke et al., 
2015) (B) Analysis of the number of AP positive hiPSC colonies, at reprogramming day 30. 
(C) Representative flow-cytometry analyses of mESCs undergoing differentiation (48hr 
treated with +FBS –LIF medium) in the presence of induced Tdp-43 (+dox) and of control 
cells (-dox). 
 
Taken together, we discover how post-transcriptional regulation 
concomitantly dissolves PSC self-renewal and promotes differentiation in a 
lineage independent fashion. This is a primary proof of uncoupling of exit 
from pluripotency and fate commitment (Fig. 44) through mutual feedback 
regulation between paraspeckles and TDP-43, which promotes the efficient 
transition between pluripotent and differentiated cellular fates. 
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Fig. 44. A model depicting TDP-43- and paraspeckle-mediated mutually 
excusive stabil ization of pluripotency and differentiat ion states.  *The model 
outlines the possibly that pluripotency mRNAs, including LIN28A and REX1, and the TDP-43 
protein promote exit from pluripotency by becoming sequestered in paraspeckles. 
Consistent with this model, our data confirmed the chromatin enrichment of the NEAT1v2 
isoform in early-differentiated hESCs, and conversely the nucleoplasmic localization and the 
rapid degradation of the NEAT1v1 isoform in undifferentiated ESCs (Fig. 38).  
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4  DISCUSSION 
 
4.1 DEVELOPMENTAL ONTOGENETIC RBPOME UNCOVERS DYNAMIC 
RNA BINDING PROTEINS 
 
Numerous studies have recently clarified that gene expression in 
eukaryotes involves tight regulation on the RNA level ensuring that correct 
complement of mRNAs and protein quantities are produced in cells 
(Schwanhausser et al., 2011). It is an established theme that the copy 
number of a given transcript in the cell can only partially explain the quantity 
of the respective protein, but little is known to what degree the amount of 
protein explains its functionality. In particular, the open question remains to 
what degree are RBPs bound to RNA targets and in this way functional. I 
used the mRNA-RBP occupancy method for this purpose to assess what 
proportion of the RBP is mRNA bound at certain cell stage and to address a 
central question whether we can determine level of RBP functionality in given 
cell type and if there is a switch in functionality between different cell states. 
Stem cells are ideal biological system to study functionality of cohorts of 
RBPs that are specifically expressed in continuum of pure pluripotency 
cultures of naïve-limes-epiblast PSCs, and sorted homogeneous progenitor 
populations that emerge from epiblast PSCs. This system also presents a 
foundation for functional analysis of the leading candidates for the respective 
developmental pre-mRNA processing changes. Intriguingly, upon generating 
first global analysis of changes in RBP functionality, I didn’t observe 
significant changes in abundances of splicing factors in early pluripotency 
transitioning and commitment despite global changes in post-transcriptional 
landscape. This hints that possibly dynamic nature of RBPs is sufficient to 
remodel developmental alternative splicing and polyadenylation landscape. 
This called for in depth analysis of altered RBP functionality during stem cell 
transitions without changes in RBP abundance. 
 
  A global mRNA-RBP occupancy has already been conducted with 
mESCs (Kwon et al., 2013), however only in steady state, providing mainly 
static information on RBPome composition. Hence, little is known about the 
developmental dynamics of changes in the RBPome composition, whether 
these changes are the result of signaling pathway activity, whether the RBPs 
are developmentally dynamic in its function and whether we can determine 
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level of RBP functionality in given cell type. Normalization of RBPome 
analysis to corresponding protein abundance reveals the extent of RBP 
functionality to form dynamic mRNPs in different developmental stages, 
hinting the change in functionality of the protein.  
 
Together, my mRNA-RBP occupancy assay constitutes the first ever 
definition of RBPome in an ontogenetic system of an unbiased and 
systematic approach for detection of the entire repertoire of RBPs in early 
stem cell priming and differentiation. In addition, my work for the first time 
explains multiple cases of mRNA occupancy changes in relation to pathway 
activation scenarios thereby presenting dynamic composition of RBPs in 
early embryonic development. Insight into RBPome changes during early 
embryonic stem cell development was enabled by further improvement of 
mRNA-interactome approach resulting in reducing protein background and 
thereby generation pure set of 676 RBPs. This discovery rate is very high 
considering that my analysis utilized <5% of the starting material that was 
used in a previous study, which identified 555 RBPs in mESCs grown in 
serum and LIF (Kwon et al., 2013), conditions allowing spontaneous 
differentiation leading to heterogenous population of various cell states 
(Kolodziejczyk et al., 2015). Moreover, my RBPome data overlapped with 
majority of an annotated list of RBPs (Gerstberger et al., 2013) (Fig. 19B). By 
including two technical controls for determination of RBP candidates, I 
stumbled to computational problem as the background signal in both 
negative control couldn’t be quantified for many identified RBPs. This 
contributed to more challenging data analysis, but at the same time it also 
confirms that the generated RBPome indeed represents bona fide RBPs 
including hundreds of previously known RBPs.  
 
During stem cell commitment and early differentiation I for the first time 
confirmed high dynamicity of the mRNA-RBP occupancy by comparing 
changes in the RNA-bound fraction by comparing ratios the total proteome 
changes. I observed that vast majority of RBPs (>80%) do not exhibit 
abundance differences in the RBPome relative to their whole cell amount 
between any stages of ESC commitment and differentiation. These results 
are in line with my expectations because many RBPs have “house keeping” 
functions, and are therefore either not expected to change or exhibit 
changes that are scaled between developmental states. I aimed to shed 
more light on dynamic RBPs that exhibit changes in the RNA bound fraction 
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but such that are not correlated with changes of their overall proteome 
amount between the stages (~5% of all RBPs, called dynamic RBPs).  
 
4.2 SIGNALING INDUCED CHANGES IN RBP DYNAMICITY AND 
FUNCTION 
 
Data integration of RBPome with proteome enabled insight into new 
links between RNA processing and early development in a dynamic 
ontogenetic time course. It has already been proposed that differentiation 
signals affect diversity of protein function in different conditions by altering its 
protein interaction partners (Kloet et al., 2016) or posttranslational 
modifications (Heyd and Lynch, 2010). To my knowledge, this is the first 
study of the effect of differentiation signals on the landscape and activity of 
mRNPs. First I observed that dynamic RBPs exhibit enrichment of translation 
related molecular functions (Fig. 20). Of the RBPs that exhibit enrichment in 
mRNA binding in the primed state (Fig. 19), we noted in particular LIN28A, 
which was recently identified as MAP kinase target that efficiently 
phosphorylate S200 LIN28A to elevate its protein levels (Tsanov et al., 2016). 
In pluripotent stem cells MAP kinase activity primes PSCs for the 
pluripotency transition and lineage commitment.  
 
Any posttranslational modification can influence, activity and function 
and even localization of modified RBP. I postulated that the functions of 
dynamically bound RBPs are modified and orchestrated via signaling 
pathways that dictate stem cell commitment and priming Therefore I 
assumed that MAPK dependent LIN28A phosphorylation upon PSC priming 
correlates with changes in LIN28A mRNA binding. I first confirmed that 
LIN28A phosphorylation elevates the protein stability, but intriguingly results 
in even 2fold higher mRNA occupancy. LIN28A defines stemness by 
repressing biogenesis of the let-7 family, but beyond this role, LIN28A is a 
strong translational regulator of pluripotency and splicing factors (Cho et al., 
2012), making it an RBP with profound effect on pluripotency. Despite being 
generally well-studied protein, studies reported opposing observations on 
LIN28A subcellular localization. The protein is generally considered to be 
predominantly cytoplasmic, where it binds pre-let-7 to block its processing 
and instead induces 3’-end oligouridylation (Balzer and Moss, 
2007),(Piskounova et al., 2011). In contrary to established LIN28A 
cytoplasmic role in let-7 repression, systematic study of early mouse 
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embryonic development observed accumulation of LIN28A exclusively in the 
mature nucleolus in mouse preimplantation embryos and partial nucleolar 
localization also in PSCs where it colocalizes with the nucleolar markers 
(Vogt et al., 2012).  
 
 
4.3 IDENTIFYING NOVEL SUBNUCLEAR ROLES OF DYNAMIC RBPS THAT 
ACT AS STEM CELL DIFFERENTIATORS 
 
 
As RBPome identified LIN28A as one of most dynamic RBPs, I 
monitored its localization dynamics during pluripotent stem cell transition and 
exit. To circumvent limitations of antibody staining and fluorescent fusion-
proteins and to cross-validate between the two techniques, I used both 
CRISPR generated fusion fluorescent proteins and a set of 3 different 
antibodies against LIN28A to compare and confirm the localization patterns. 
Both in vivo and in fixed cell cultures I observed extensive LIN28A 
translocation to cytoplasm that reflects also increased mRNA occupancy 
following exit of naïve and suggests active regulation of RNA binding of some 
RBPs.  
 
Whether LIN28A has nuclear roles is to date still unknown. The Daley 
lab hypothesized that nuclear LIN28 could also directly regulate alternative 
splicing (Shyh-chang and Daley, 2013), for what I provided first initial 
evidence (Fig. 23). Additionally, by integrating information that LIN28A is 
predominantly nucleolar in naive PSCs, but let-7 is nevertheless repressed in 
naive PSCs (Tsanov et al., 2016), I postulate dual LIN28A-dependent 
mechanims of let-7 repression. I first measured let7 miRNA levels that were in 
total not significantly changed between naive and primed pluripotent stem 
cells. This hinted even nuclear dependent mechanism of let-7 repression, 
since LIN28A is localized to nucleoli in naïve PSCs (Figs. 45A, 23A). To 
further dissect the mechanism of the nuclear Lin28A-mediated let-7 
processing block I tested whether LIN28A co-localizes with pri-let7. Indeed, I 
observed that primary let7 transcript is sequestered to nucleoli (Fig 45B), 
where it cannot be processed by DGCR8 and Drosha, which are excluded 
from nucleoli (Piskounova et al., 2011). 
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Figure 45: LIN28A represses let-7 biogenesis in the nucleolus of naïve PSCs. 
(A) Confirmatory RT-qPCR analysis of let-7 miRNA isoforms showing showing similar 
expression levels of let-7 isoforms in naïve and primed PSCs (Error bars are SEM of n=3). 
(B) Representative deconvolved maximum projection photomicrographs taken with smFISH 
probes used for detecting pri-let7g on LIN28-eGFP mouse naïve PSCs. LIN28 fusion protein 
and pri-let7g co-localize with each other as indicated with arrows. 
 
Furthermore, LIN28A has nucleolar localization pattern also in non-human 
primate preimplantation embryos, but is exclusively cytoplasmic protein in 
non-human primate PSCs (Vogt et al., 2012). I confirmed that LIN28A is 
exclusively cytoplasmic also in human PSCs, but following stem cell 
differentiation LIN28A accumulates in the nucleus with preferential 
localization in the nucleolus (Fig. 23A). Taken together, LIN28A has species-
specific localization patterns, which is intriguing for highly conserved 
pluripotency factor. 
Additionally, by simultaneously mutating both LIN28A RNA binding 
domains (CCHC and CSD) LIN28A exhibits entirely nuclear localisation in 
cells where it normally acts as cytoplasmic RBP (Balzer and Moss, 2007). 
These findings suggest RNA-dependent RBP transport. Whether this active 
and cell state regulated transport is dependent on PTM, RNA binding or 
formation of specific RNP complexes remains to be elucidated. 
It remains to be elucidated whether the protein has 
nucleolar/cytoplasmic redundant function in repressing let-7 biogenesis. 
However, specificity of LIN28A is not limited to miRNA molecules as LIN28A 
binds a myriad of mRNAs to modulate their translation. In this way LIN28A 
functionally exhibits two distinct molecular mechanism, let-7-dependent 
(nucleolar and cytoplasmic) and let-7-independent (cytoplasmic). Further in 
depth mechanistic studies of LIN28A will advance our understanding what is 
essential LIN28A function for pluripotency maintenance and somatic 
reprogramming. Furthermore, as already known pluripotency factor LIN28A 
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was identified as highly dynamic RBP, it is intriguing whether a subset of 
novel dynamic RBPs has a general role in maintenance of pluripotency and if 
so, how is their function altered upon pluripotency breakdown. 
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4.4 DISSECTING THE POST-TRANSCRIPTIONAL MECHANISM OF 
LINEAGE RESTRICTION BY DYNAMIC RBPS 
 
In further attempt to dissect the post-transcriptional mechanism of 
lineage restriction, I showed that TDP-43 is an evolutionary conserved global 
developmental regulator of APA regulatory programs in PSCs and their 
progenitor progeny (Fig. 14 for mouse and Figs. 26 for human PSCs). TDP-43 
decrease takes place during early differentiation of h/mESCs (Fig. 27D-E). To 
independently identify the primary mechanisms that regulate the APA 
changes during PS differentiation, we analyzed the sequence motifs around 
PAS and identified enrichment of GUG, canonical TDP-43 binding site (Fig. 
26). Mechanistically TDP-43 has a position dependent bimodal effect on 
determining PAS locations (Fig. 30), both towards lengthening and 
shortening of 3’ UTRs and thereby it regulates an evolutionary conserved 
switch in APA of hundreds of transcripts during early differentiation of mouse 
and human PSCs (Fig. 27A). Amongst others, TDP-43 developmental 
depletion subsequently leads to APA of SOX2, which exposes this core 
pluripotency factor to miR-mediated decay (Fig. 31). While the effect of TDP-
43 on SOX2 expression can explain why TDP-43 is essential for early 
development (Sephton et al., 2012), and why it promotes cellular 
reprogramming and inhibits PSC differentiation, it is likely that additional RNA 
targets contribute to this phenotype. Important TDP-43 target is NEAT1 on 
which TDP-43 promotes production of a short isoform, which is quickly 
degraded, and thus cannot act as a scaffold for paraspeckles (Fig. 32). The 
decline of TDP-43 during differentiation ensures that the decrease of SOX2 
coincides with the production of full-length NEAT1 that forms paraspeckles. 
These subnuclear aggregates then in turn recruit TDP-43 and relocalise it 
away from its other RNA targets.  
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4.5 CROSS-REGULATION BETWEEN TDP-43 AND PARASPECKLES 
PROMOTES PLURIPOTENCY- DIFFERENTIATION TRANSITION BY 
FORMATION OF ATTRACTOR FOR PLURIPOTENCY DISSOLUTION 
 
Collectively, my data indicate that paraspeckles functionally oppose 
TDP-43, and this cross-regulation creates a 
bimodal network of antagonizing dual 
stable states that mediate paraspeckle 
inhibition in pluripotent state and formation 
of paraspeckles upon differentiation. In this 
way TDP-43-paraspeckle axis serves to 
stabilize mutually exclusive states of 
pluripotency and differentiation. I predict 
that the components of paraspeckles act in 
a feed-forward manner (non-linear 
amplification) to assemble when the 
components reach a certain threshold, and 
below the threshold at the same 
components repress paraspeckle 
assembly and contribute to stabilization of 
the pluripotency state. Taken together, in 
my thesis I uncover how post-
transcriptional regulation concomitantly 
dissolves stem cell self-renewal and 
promotes differentiation in a lineage 
independent fashion. This is to my 
knowledge a primary proof of uncoupling 
of exit from pluripotency and fate 
commitment (Fig. 46). 
 
Figure 46: The model for the cross-
regulating role of TDP-43 and paraspeckles 
in the regulation of APA in ESCs, 
dif ferentiat ion and reprogramming.  
 
 
One molecular behavior module that possibly could explain the role of 
TDP-43 regulated paraspeckles in exit from pluripotency is that they serve to 
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generate an attractor state for differentiation. Such an attractor state can 
negate pluripotency in a way that further suppresses pluripotency. The 
existence of differentiation attractors has been postulated for PSCs (Enver et 
al., 2009), but to date none have been identified experimentally and I here 
provide first biological insight into a possible attractor mechanism that leads 
to reduction of pluripotency though paraspeckle formation.   
 
4.6 DISCOVERING THE PROCESS OF LIQUID PHASE TRANSITION IN 
CELL FATE TRANSITIONS 
 
Moreover, paraspeckles have been shown to interact with proteins that 
contain prion-like domains (Hennig et al., 2015). It is likely that the 
scaffolding activity of NEAT1 coordinates the tendency of prion-like domains 
to undergo phase transitions (March et al., 2016), thus leading to the 
membraneless organelle formation within paraspeckles (Naganuma et al., 
2012; Nishimoto et al., 2013; West et al., 2016). This unravels a bimodal 
equilibrium that regulates cell states via a network of RBPs and a 
macroscopic RNP granule formed on a lncRNA. It has been proposed that 
paraspeckles are liquid droplets, implicating the recently discovered process 
of liquid phase transition in cell fate transitions (March et al., 2016). To the 
best of my knowledge, PhD thesis discoveries constitute the first proof that 
such a network is based on the formation of RNA granules.  
 
Furthermore, paraspeckles have previously been linked to diverse 
etiologies, including cancer and neurodegeneration (Adriaens et al., 2016; 
Nishimoto et al., 2013). To date, more than 40 proteins are known to 
associate with paraspeckles (Naganuma et al., 2012), including several key 
molecular players involved in pathogenesis of ALS and FTLD, like TDP-43, 
FUS, TAF15, EWSR1 and hNRNP-A1 are components of paraspeckles 
(Shelkovnikova et al., 2014). Furthermore, six paraspeckle proteins are 
known to cause ALS when mutated. In addition, among known paraspeckles 
proteins have hnRNP-A1, hnRNP-H, hNRNP-K and FUS already been 
reported to colocalize with (G4C2)n RNA foci, most common ALS hallmark, 
further strengthening the role of paraspeckles in C9ORF72 ALS pathology 
(Cooper-Knock et al., 2014, 2015; Lee et al., 2013; Rossi et al., 2015). To 
further expand on the role of paraspeckles on neurodegeneration, we in 
collaborative efforts with Rogelj lab showed that ALS-causing (G4C2)n RNA 
foci form paraspeckle-like structures, which modulate nuclear 
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compartmentalization of paraspeckle-bound RNAs. We even show that 
(G4C2)n RNA foci form paraspeckle-like structures, which may function in 
similar fashion as paraspeckles and modulate nuclear compartmentalization 
of paraspeckle-bound RNAs (Darovic et al., in review, data not shown). Our 
results add additional evidence to the role of paraspeckles in pathogenesis 
of ALS and FTLD, however the exact mechanism linking paraspeckles to 
disease in C9ORF72-positive and negative cases still remains to be 
discovered.  
 
It would be intriguing to determine sequence requirements of RNAs 
that can attract paraspeckle proteins and form paraspeckle-like structures. 
Our results even indicate that (G4C2)n RNA foci might replace NEAT1 and 
scaffold the formation of paraspeckle-like structures. This is even 
contradictory with the established dogma, where NEAT1v2 is required for 
paraspeckle formation and integrity (Naganuma et al, 2012) and raises a 
question whether NEAT1v2 is truly indispensable for paraspeckle formation. 
Although this comes a step closer in connection of paraspeckles to 
neurodegeneration, it still needs to be further elucidated whether nuclear 
accumulation of RNAs is a critical step in disease mechanism. 
 
4.7 ROLE OF TDP-43/NEAT1 AXIS IN DISEASE 
 
It should also be noted that just like the perturbations in LIN28/let-7 
network, which are manifested in developmental disorders and cancer 
(Powers et al., 2016; West et al., 2009), perturbations in TDP-43/NEAT1 
cross-regulation might contribute to amyotrophic lateral sclerosis and other 
diseases (Adriaens et al., 2016; Hennig et al., 2015; Nishimoto et al., 2013; 
Tollervey et al., 2011b). Paraspeckles are likely to have additional functions 
beyond recruiting TDP-43, since they are a non-membrane bound organelle 
that might induce phase separation of multiple RBPs (Hennig et al., 2015). 
Therefore, I speculate that paraspeckles remodel the nuclear RNA regulatory 
landscape in a way that facilitates the exit from the pluripotent state. Several 
mRNAs that are crucial or are specifically expressed in PSCs and are 
subsequently sequestered in paraspeckles (Chen and Carmichael, 2009; 
Chillón and Pyle, 2016). A notable example is the transcript of LIN28A that 
contains an Alu inverted repeat (IR) region which was proposed to serve as a 
template for RNA-editing and paraspeckle retention (Chen et al., 2008; 
Prasanth et al., 2005). As exogenous expression of LIN28A in somatic cells 
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enhances the translation of TDP-43 (Wilbert et al., 2012), this hints to even 
expanded feed-back loop between LIN28 and TDP43, centered around 
NEAT1 regulation. 
 
 
 
Materials and methods 
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5 MATERIALS AND METHODS 
 
5.1 CELL CULTURE 
 
Mouse ESC and iPSCs were maintained on gelatin-coated plates in 1:1 
neurobasal medium (Life technologies, 21103049) and DMEM (Life technologies, 
11320033), supplemented with N2 / B27 (Life technologies, 17502048, 17504044),  
supplemented with MEK inhibitor PD0325901 (1 μM), GSK3 inhibitor CHIR99021 (3 
μM) (1408 Axon Medcham and 4953/50 Tocris, respectively), 1,000 U/ml LIF (in-
house production), 1% Glutamax (Life Technologies, 35050038), 0.1mM 2-
mercaptoethanol (Thermo Fisher Scientific, 31350-010), 1% nonessential amino 
acids (Thermo Fisher Scientific, 1140050). Cells were passaged by trypsinization 
(Life Technologies, 25200056). Spontaneous differentiation was induced by the 
omitting LIF and replacing N2B27 with HyClone™ Fetal Bovine Serum 
(SV30160.03HI GE Healthcare).  
 
H9 human ESCs (H9 line) were cultured in mTeSR1 medium (05850, Stem 
Cell Technologies) on Matrigel (diluted 1:1000, 5ml, coating of 10cm plates for 1hr 
at 37°C., 356234 BD Biosciences)-coated plates. Colonies were passaged by 
gentle cell dissociation reagent (07174, StemCell Technologies). 
 
HESCs differentiation to PS progenitors was induced by dissociation of 
colonies into single cells using Accutase (A6964, Sigma) and seeding on Matrigel-
coated plates with mTESR1 medium supplemented with 10µM ROCK inhibitor 
(ROCKi Y-27632, 1254/10, R&D Systems) at 100% confluency. Next day cells were 
washed with PBS, and the medium was changed to RPMI1640 medium (11875093) 
supplemented with L-Glutamine (25030081), B27 minus insulin (A1895601) all from 
Thermo Fisher Scientific, 10µM ROCKi and 10µM CHIR99021. Differentiation into 
trophoblasts was induced by dissociation of colonies using 0,25% Trypsin-EDTA 
(25200056, Thermo Fisher Scientific) and seeding as single cells (105,000 
cells/cm2) on Matrigel-coated plates in DMEM/F12 medium (11320082), 
supplemented with 20% KnockOut Serum Replacement (Thermo Fisher Scientific, 
10828028), Glutamax, nonessential amino acids, beta-mercaptoethanol, and 50 
ng/ml BMP4 (314-BP, R&D systems). Medium was changed daily. 
 
EpiSCs were cultured on gelatin and fetal calf serum-coated plates in N2B27 
supplemented with 20 ng/ml ACTIVIN A (338-AC-050, RnD), 12 ng/ml FGF2 (100-
18B , Peprotech) and 3µM IWP2 (sc-252928, Santa Cruz Biotechnology). EpiSC 
differentiation to PS progenitors was induced by dissociation of colonies with 
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collagenase and and seeding on gelatin-coated plates in N2B27 supplemented with 
20 ng/ml ACTIVIN A (338-AC-050, RnD), 12 ng/ml FGF2 (100-18B , Peprotech) and 
200ng/ml Wnt3a (in house production, ErasmusMC, lab of Derk ten Berge). 
 
 Mouse embryonic fibroblasts (MEFs) were maintained in DMEM 
supplemented with 10% FBS, L-glutamine and penicillin/streptomycin on gelatin-
coated plates. 
The HEK293 Flag-TDP-43 inducible cell line was cultured as previously described 1 
 
5.2 HUMAN FIBROBLAST REPROGRAMMING 
 
1. Reprogramming of primary neonatal human dermal fibroblast (NHDF) 
For reprogramming of primary neonatal human dermal fibroblast (NHDF), the cells 
were harvested using 0.25% Trypsin-EDTA, counted and 1.5x10E6 cells were 
resuspended in MEF 1 Nucleofector® Kit (VPD-1004, Lonza) solution with 6µg of 
plasmid DNA, MIP 247 CoMiP 4in1 with shRNA p53 and pCXLE-hMLN (63726 and 
27079 Addgene). The cells were pulsed with T-020/N- 024 programs using the 
Nucleofector™ 2b Device (AAB-1001, Lonza). One transfection was divided and 
plated in three wells of a Matrigel (FALC354230 Schubert&Weiss) coated 6 well 
tissue culture dish with fibroblast medium composed of 10% HyClone™ Fetal 
Bovine Serum (SV30160.03HI GE Healthcare), 0.2 mM sodium butyrate and 50 
μg/mL ascorbic acid. After the first iPSC-like colonies appeared, between days 15-
20, medium was switched to Essential 8 (Thermo Fisher, A1517001) supplemented 
with 0.2 mM sodium butyrate and 50 μg/mL ascorbic acid in hypoxic conditions. 
Around days 25–30, the iPSC colonies were large enough for manual selection and 
counting under the microscope 
 
2. Reprogramming of Secondary human fibroblasts (HiF-Ts) 
Secondary human fibroblasts (HiF-Ts) were cultured and reprogrammed as 
described previously 2. Alkaline phosphatase staining (Blue membrane substrate 
solution AB0300-1KT, Sigma) was used to detect reprogrammed colonies, and 
reprogramming efficiency was determined as the ratio of reprogrammed colonies 
relative to the number of the initial cells. 
 
5.3 RNA EXTRACTION AND (Q)RT-PCR ASSAYS 
 
Total RNA was extracted from cell pellets using miRNeasy mini kit (Qiagen, 
74104) according to the manufacturer’s instructions. First-strand cDNA synthesis of 
1 µg total RNA was performed using SuperScript III Reverse Transcriptase 
(18080085, Invitrogen), according to the manufacturer’s instruction. RT-qPCR 
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reactions were performed using FastStart Universal SYBR Green Master 
(4367659,Thermo Fisher). Primers used in this study include: 
 
TaqMan Gene Expression Assay, Assay ID:Hs03924655_s1 (human Neat1v2) 
TaqMan Gene Expression Assay, Assay ID: Hs01053049_s1 , Gene Symbol: SOX2 
TaqMan Gene Expression Assay, Assay ID: Hs02758991_g1, Gene Symbol: 
GAPDH 
TaqMan Gene Expression Assay, Neat1, Assay ID: Hs01008264_s1 (Neat1v1) 
TaqMan Gene Expression Assay, Assay ID: Hs00999632_g1 , Gene Symbol: Pou5f1 
TaqMan® Gene Expression Assay, Assay ID: Hs03309805_s1, Gene Symbol: 
SCARNA10 
TaqMan® Gene Expression Assays, Assay ID: Mm03455878_s1 (mouse Neat1v1) 
 
5.4 SINGLE MOLECULE FISH AND PARASPECKLE QUANTIFICATION 
 
Single molecule FISH in mammalian cells was done according to Raj et al3. 
Briefly, cells that were grown on sterile 2-well µ-Slides (Ibidi) were washed twice 
with 1x PBS (5 min each) and fixed with 4 % Paraformaldehyde (methanol-free; 
Fisher Scientific) for 10 min at RT. After two washes with 1x PBS (5 min each), cells 
were permeabilized in 70 % ethanol at 4 °C for >12 h. Cells were washed twice with 
1x PBS (5 min each) and then incubated for 15 min in 2x saline-sodium citrate (SSC) 
buffer with 10 % formamide (deionized; Merck Millipore). Hybridization with 
Stellaris® FISH probes was done in 50 µl hybridization buffer containing 2x SSC, 10 
% formamide, 50 µg competitor E.coli tRNA (Roche Diagnostics), 10 % Dextrane 
Sulfate (VWR), 2 mg/ml BSA (UltraPure; Life Technologies), 10 mM vanadyl-
ribonucleoside complex (NEB) and 1 ng/µl probe mix for NEAT1 5`end and middle 
segment. Cells were covered with parafilm and incubated at 37 °C for 5-6 hours. 
After washing twice with pre-warmed 2xSCC/10 % formamide for 30 min at 37 °C, 
cells were washed twice with 1x PBS at RT and then mounted with 10 µl ProLong® 
Gold Antifade Reagent containing DAPI (NEB). Cells were imaged by Markus 
Grosch after 12 hours when the mounting medium was fully cured.  
 
Probes were designed using the Probe Designer software provided by 
Biosearch Technologies. Probes used were hNEAT1 middle segment conjugated to 
Quasar®570 (pre-designed by Biosearch Technologies), hNEAT1 5` segment 
conjugated to Quasar®670 (custom-made), mNEAT1 middle segment conjugated 
to Quasar®670 (custom-made) and mNEAT1 5` segment conjugated to 
Quasar®570 (custom-made).  
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Paraspeckle quantification was done by Markus Grosch in a 3D stack using 
the spot detection algorithm Airlocalize4. 7-10 images containing 40-150 cells each 
were averaged to calculate number of paraspeckles per cell.  
 
5.5 QUANTSEQ T-FILL 3’MRNASEQ 
 
3 µg of RNA was treated with TURBO DNase (am2238, Thermo Fisher 
Scientific) according to manufacturer’s instructions followed by RNeasy Minelute 
RNA cleanup (74204, Qiagen). Microcapillary electrophoresis on Agilent 2100 
Bioanalyzer with RNA Pico 6000 kit (Agilent, 5067-1513) was used to analyze RNA 
quality (RIN values >8). 0.5 µg of RNA was used for making libraries for sequencing 
using Lexogen QuantSeq-REV kit (016.24, Lexogen GmbH) according to 
manufacturer’s protocol, using a poly(T) primer for reverse transcription. The library 
was sequenced using Illumina HiSeq, producing 60 nt single-end reads and 10 nt 
index reads. 
 
5.6 TOTAL RNA SEQUENCING 
 
3 µg of RNA was treated with TURBO DNase (Life Technologies, am2238) 
according to manufacturer’s instructions followed by RNeasy Minelute RNA cleanup 
kit (Qiagen, 74204). Microcapillary electrophoresis on Agilent 2100 Bioanalyzer with 
RNA Pico 6000 kit (Agilent, 5067-1513) was used to analyze RNA quality (RIN 
values >8). Per RNA-seq library, 1 µg of DNAse-treated RNA was treated with 
RiboZero Gold (Human/Mouse/Rat) kit (Illumina, RS-122-2301) to remove rRNAs, 
followed by RNA cleanup using the RNeasy Minelute RNA cleanup kit. Sequencing 
libraries were prepared using TruSeq Stranded total RNA LT kit (Illumina, RS-122-
2301) according to manufacturer’s instructions using 11 cycles of PCR followed by 
purification with Agencourt Ampure XP beads (Beckman-Coulter, A63881). Libraries 
were evaluated on an Agilent 2100 Bioanalyzer using the DNA 1000 kit (Agilent, 
5067-1504). DNA concentration was measured using a Qubit dsDNA HS Assay Kit 
(Life Technologies, Q32854). Samples were sequenced using a HiSeq2500 
instrument to generate 50-nt single-end reads, sequencing depth was 20–40 Mio 
reads per library. Multiplexing of libraries was performed according to 
manufacturer’s instructions. 
5.7 NASCENT RNA-SEQ 
 
Metabolic RNA labelling in ES cells was done by adding 0.4mM EU (5-
ethynyl uridine) into the growth medium for 40 min immediately before cell lysis at 
the indicated time points. Total RNA was prepared using RNeasy mini kit (Qiagen, 
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74204).  For RNA sequencing of nascent transcripts, 10 µg of total RNA was first 
depleted of ribosomal RNA using Ribo-Zero rRNA remonal kit (human/mouse/rat) 
(Illumina, RS-122-2301) and purified using RNeasy MinElute cleanup kit (Qiagen). 
rRNA-depleted, EU-labelled RNA (0.5-1 µg) was biotinylated and captured using 
Click-it Nascent RNA Capture Kit (Thermo Fisher Scientific, C10365) according to 
manufacturer’s instructions. Briefly, RNA was biotinylated with 0.5 mM biotin azide in 
Click-iT reaction buffer followed by ethanol precipitation. Purified biotinylated RNA 
was incubated with Dynabeads MyOne streptavidin T1 magnetic beads (Thermo 
Fisher Scientific, 65601),  at 68°C for 5 min and room temperature for 30 min. Beads 
with bound RNA were washed with Click-iT wash buffers 1 and 2. Washed beads 
were used for cDNA synthesis and subsequent RNA-seq library preparation using 
TruSeq Stranded total RNA LT kit (Illumina, RS-122-2301), according to 
manufacturer’s recommendations. Sequencing libraries for all the time points were 
pooled and sequenced on Illumina NexSeq 500 instrument using high output 
reagent cartridge producing 75 cycles of single-end reads.   
 
5.8 WESTERN BLOT 
 
Cells were trypsinized and lysed using RIPA buffer, containing phosphatase 
(Sigma-Aldrich, 4906837001) and protease (Merck, 539134) inhibitors. After 
addition of 2x SDS loading buffer with 2-Mercaptoethanol (Sigma-Aldrich, M3148) 
samples were heated at 95°C for 5 minutes. Samples were run on Mini-PROTEAN 
TGX Stain Free Gels, 4-15% (Bio-Rad Laboratories, 456-8086) and blotted using the 
Mini Trans-Blot Cell (Bio-Rad Laboratories, 1703930). Following 3x 5 min washing 
steps with TBS-T, membranes were blocked with 5% milk powder (Carl Roth, 
T145.1) in TBS-T. Membranes were then incubated over night at 4°C with 5% milk 
powder in TBS-T containing the primary antibody. After 3x 5 minutes TBS-T washing 
steps the membrane was incubated with goat anti-rabbit IgM-HRP (Santa Cruz, sc-
2030) in 5% milk powder in TBS-T. Following 4 washing steps, 15 minutes each, 
with TBS-T the membrane was incubated for 1 min with Clarity Western ECL 
Substrate (Bio-Rad Laboratories, 170-5060) and imaged with ChemiDoc™ MP 
System (Bio-Rad Laboratories) or exposed to x-ray film. Antibodies used are listed 
below. 
Human Pluripotent Stem Cell Array Dot blot (ARY010, R&D Systems) was 
used to measure pluripotency factors  according to manufacturer’s instructions. 
 
5.9 IMMUNOFLUORESCENCE 
 
Cells were grown in Matrigel coated 8 well chamber slides (Ibidi, 80826) and 
fixed with 4% PFA/DPBS solution (Pierce™ 16% Formaldehyde (w/v), Methanol-free 
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28906 Thermo Fisher ScientificTM) for 15 min at RT and permeabilized with 0.2% 
TritonX-100/DPBS (9002-93-1, Sigma Aldrich) solution for 15 min at RT. Primary and 
secondary antibodies were diluted to data sheet indicated concentrations in 
10%FBS/0.2% TritonX-100/DPBS and incubated respectively overnight at 4°C and 1 
hour at RT. The samples were washed with DAPI (50ug/ml) solution and imaged 
using a Zeiss Axiovert 200M epifluorescent microscope. 
 
 
All antibodies used for western blot and immunofluorescence:  
Name Type Reactivity Host Cat. # Company 
Oct-04 mAB  human, mouse rabbit 2840 
Cell 
Signalling 
SOX2 mAB mouse, human rabbit 23063 
Cell 
Signalling 
NANOG mAB human rabbit 4903 Cell Signalling 
TDP-43 polyclonalAB human, mouse rabbit 1078-2-AP Proteintech 
TDP-43 polyclonalAB mouse, human rabbit SAB4200006 Sigma 
SFPQ mAB mouse, human mouse MA1-25325 
Thermo 
Fisher 
NONO polyclonalAB mouse, human rabbit ab70335 Abcam 
CPEB1 polyclonalAB mouse, human rabbit 3583 
Cell 
Signalling 
pSMAD2 mAB mouse, human rabbit 8828 
Cell 
Signalling 
SMAD2 mAB mouse, human rabbit 8685 
Cell 
Signalling 
GDF3 polyclonalAB mouse, human goat AF958 RnD 
 
5.10 SHRNA AND SIRNA KNOCKDOWN 
 
We used shRNA targeting human TDP-43 (GAAACACAAGTGAAAGTAA) or 
a control targeting firefly luciferase (CGTACGCGGAATACTTCGA) driven by the H1 
promoter in the vector FUW coexpressing TagRFP both for transfection and 
transduction. TDP-43 overexpression lentiviral construc consists of myc-HA tagged 
TDP-43 that was expressed from a lentivirus plasmid driven by ubiquitin promotor. 
All Lentiviral particles were produced in HEK293FT cells (Life Technologies) as 
described previously 5. All lentiviral constructs were a gift from Dieter Edbauer 6.  
 
Transfection siRNA for TDP-43 knock-down in hESCs cells was carried out in 
6 well plates. Each siRNA oligo was transfected using Lipofectamine RNAi MAX 
(Invitrogen, 13778150) according to manufacturer′s instruction. Prior to transfection, 
cell colonies were dissociated into single cells using accutase (Sigma, A6964) and 
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subsequently seeded onto Matrige-coated 6-well plates containing mTESR1 
medium  supplemented with ROCKi at 100% confluency. On the next day after 
seeding, siRNA transfection was performed using 5 nM siRNA duplexes against 
TDP-43 mixed with 5 μl of transfection reagents in 100 μl DMEM. A Stealth RNAi™ 
siRNA negative control (Invitrogen, 12935-200) was used as negative control. The 
mixture was incubated at room temperature for 20 min and dropwise added to the 
cells. The following siRNA sequence was used to target TDP-43 (Invitrogen, A-
012394-14,  5’-GGCUCAAGCAUGGAUUCUA-3’).  
 
5.11 GENERATION OF INDUCIBLE TDP-43 OVER EXPRESSION LINE 
 
mESC with inducible TDP-43-GFP overexpression were generated by 
targeting A2-lox ES cells 7 with p2lox-TDP-43-GFP human construct. A2-lox-cre cell 
line in which genes of interest could be targeted to a specific conditionally regulated 
Rosa26 locus. 2days prior to recombination, 1:1000 doxycycline of doxycycline 
stock (2mg/mL, Sigma D9891-1G) was added to the cells to induce Cre that is 
expressed under the control of tetracycline response element (TRE). Cells were 
transfected with p2lox-TDP-43-GFP construct using Lipofectamine 2000 
(LifeTechnologies, 11668019) according to manufactorer’s instructions. The cre 
cDNA excises itself after recombination and placement of the p2lox-TDP-43-GFP 
behind the TRE, resulting in highly efficient generation of TDP-43-GFP inducible 
overexpressing cell line. Following the transfection, the cells were allowed to 
recover for 24 hours in nonselective naïve mESC medium and 24 hours later 
selective naïve mESC medium containing G418 (250 ng/ml final concentration) was 
added for 7-8 days. After this period only single clones were selected and 
expanded to obtain inducible TDP-43-GFP overexpression mESC line.  
Inducible Flag-TDP-43 HEK293 flip-in cell line was used for Fig. 32 experiments1. 
 
5.12 FLOW CYTOMETRY ANALYSIS 
 
Flow cytometry analysis of the SOX2-GFP reporter in HEK293 cells was 
conducted by harvesting the cells using Trypsine, 40 h after co-transfection 
(Lipofectamin 2000 according to manufacturer’s instructions) of respective reporters 
(Fig. 32) together with miRZIP-21-dTomato miR-21 precursor (modified upon 
MZIP21-PA-1-GVO-SBI, System Biosciences. HEK293 cells are known to express 
undetectable levels of pri-miR-218 and were therefore ideal cell system to study 
miR-21 dependent SOX2 mRNA decay. FlowJo was used for data analysis, by 
which only cells coexpressing both plasmids (enriched dTomato/eGFP signal over 
the set gate; ~20%) were considered for analysis.  For flow cytometry analysis 
coupled to antibody staining, the cells were washed once, resuspended in staining 
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media (2 - 4% FBS and 1mM EDTA in PBS), and analyzed by flow cytometry. 
miPSCs/mESCs were prepared as outlined above, and stained with a DyLight 650-
conjugated SSEA-1 antibody (clone MC-480, MA1-022-D650, Life Technologies) or 
Alexa Fluor 647 conjugated SSEA4 Mouse Anti-Human mAb (clone MC813-70, 
SSEA421, Life Technologies), and analyzed using a FACS Aria III cell sorter (BD 
Biosciences). Cell debris were excluded by forward and side scatter gating, a 561 
nm laser to detect dTomato and a 488 nm argon laser (530/30 nm bandpass filter) 
for GFP. FlowJo was used for data analysis.   
 
Reprogramming of human fibroblasts was assessed by flow cytometry with 
anti-human TRA-1-60 antibody coupled to Alexa Fluor® 647 (560122, BD 
Bioscience). Cell preparation and flow cytometry analysis was performed as above. 
Subcellular fractionation 
 
5 to 10 million cells were harvested, washed with ice-cold PBS and 
centrifuged at 500g/4°C. The pellets were gently resuspended in 380 μl cold 
cytoplasmic lysis buffer (50 mM Tris-pH 6.5, 100 mM NaCl, 300 mM Sucrose, 3 mM 
MgCl2, 0.15 % NP40) supplemented with 100 U RNasin Plus RNase inhibitor 
(PRN2615, Promega). After incubation on ice for 10 min, cells were briefly vortexed 
and centrifuged at 1000g/4°C for 3 min. The supernatant containing the cytoplasmic 
fraction was transferred, and centrifuged again at 4°C/5000 g for 2 min to remove 
cell debris. Immediately after centrifugation 1 ml of RNA precipitation buffer (RPS; 
9.5 ml 100 % EtOH with 0.5 ml 3 M Sodiumacetate) was added and the supernatant 
was incubated at -20°C for 3 to 5 hours until RNA extraction (below). 
 
The remaining pellet was washed three times with 400 μl cytoplasmic lysis 
buffer supplemented with an increasing concentration of Ammonium sulfate (50 
mM, 200 mM and 500 mM). The rationale behind this was to disrupt the 
endoplasmatic reticulum (ER) which is still attached to the nucleus without breaking 
the nuclear envelope. For each washing step, the cell suspension was centrifuged 
at 4°C and 5000 g for 2 min and the supernatant was processed as described 
below for RNA extraction 
 
380 μl of cold Modified Wuarin-Schibler (MWS) buffer (10 mM Tris-HCl pH 
7.0, 4 mM EDTA, 0.3 M NaCl, 1 M Urea, 1 % NP-40) supplemented with 100 U 
RNasin Plus RNase inhibitor was added to the remaining pellet. Samples were 
vortexed for 30 sec, incubated on ice for 5 min, then vortexed again and kept further 
on ice for 10 min. The suspension was centrifuged at 4°C/1000g for 3 min and the 
resulting supernatant representing the nucleoplasmic fraction was processed as 
described below for RNA extraction. 
 
The pellet was washed three times by adding 800 μl of MWS buffer, 
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vortexing for 30 sec and centrifuging at 4 °C/500 g for 2min. 1 ml QIAzol® (79306, 
Qiagen) was added to the remaining chromatin pellet and after short vortexing, the 
suspension was stored at -20 °C until further usage. 
 
The RNA fraction in RPS buffer was vortexed for 30 sec and after adding 1 μl 
Glycoblue (Life Technologies, AM9516) centrifuged at 4 °C/18000 g for 15 min. 1 ml 
QIAzol® was added to the partially air-dried pellet. 10 μl of 0.5 M EDTA was added 
to all samples in QIAzol® and heated up to 65 °C and incubated for 10 min to 
resuspend the pellet. After cooling down, 200 μl of Chlorophorm/Isoamylalkohol 
(24:1) was added, solution were vortexed for 30 sec and then centrifuged at 
18000g/RT for 10 min. The upper aqueous phase was transferred into a new tube 
and the same volume of isopropanol together with 1 μl of glycoblue was added. 
After ON incubation at -20 °C, the suspensions were centrifuged at 18000g/RT. The 
pellets were washed once by adding 1 ml 70 % EtOH and centrifuging at RT/18000 
g for 5 min. The pellet were air-dried for 10 min and resuspended in RNase-free 
water. Cytoplasmic, nucleoplasmic and chromatin fractions were analyzed by RNA-
sequencing as outlined above. Random primed, strand specific cDNA libraries were 
prepared following Illlumina stranded Tru-Seq LT protocol (above). 81 – 92 % of 
obtained cDNA reads after sequencing could be aligned to the human genome 
allowing a single mismatch. 
 
5.13 ICLIP ANALYSIS 
 
The iCLIP protocol was performed as described previously9, with the 
following modifications. Cells were UV irradiated once with 160 mJ/cm2 in a 
Stratlinker 1800 at 254 nm. TDP-43 was immunoprecipitated with protein A 
Dynabeads (10002D, Invitrogen) conjugated to rabbit-anti TDP-43 (Sigma, 
SAB4200006) or GFP (Life, Technologies, A6455). The region corresponding to 55–
100kDa complexes was excised from the membrane to isolate the RNA, and 
sequenced using Illumina HiSeq, instrument to generate 50-nt single-end reads, 
sequencing depth was 15- 20 Mio reads per library Analysis of reproducibility of 
crosslink sites, identification of the significant iCLIP crosslink clusters and z-score 
analysis of enriched pentamers was done as described previously 10 and data was 
processed by iCount webserver (http://icount.biolab.si). 
 
5.14 RNA-SEQ DIFFERENTIAL EXPRESSION 
 
To identify differentially expressed genes from RNA-seq data, we mapped 
the reads using tophat11. We then produced the per-gene count tables using ht-seq 
and Ensembl genome annotation v74. Finally, we applied edgeR analysis 12 to the 
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count tables, which resulted in the list of genes with respective p-value and fold-
change values on the gene level. 
 
5.15 APAEXPRESS ANALYSIS PLATFORM 
 
For the analysis of alternatively polyadenylated genes, we applied the 
analytics implemented in ExpressRNA (expressrna.org), an online research platform  
with client/server architecture for processing and computational analysis of 3’-end 
targeted sequence data13. ExpressRNA combines newly developed and existing 
bioinformatics analytics for short read alignment, feature annotation, identifying 
differentially polyadenylated genes and RNA-protein binding (CLIP) profile 
integration via RNA-maps. 
 
5.16 APA ANALYSIS 
 
QuantSeq read data were aligned to the hg19 reference genome with STAR 
aligner 14. Reads that did not align uniquely were filtered out. Identification of polyA-
site with QuantSeq relies on annealing of a polyT primer to the polyA tail of mRNAs. 
Our first step to avoid internal priming, where the primer is annealing to a genomic 
polyA sequence instead to the polyA tail, was to remove A-rich regions in vicinity of 
identified polyA-site ([-10..10]). Additionally, only polyA-site that were more than 125 
nt apart were included since cleavage is not a nucleotide exact process, and 
consequently we cluster closely spaced polyA-site. The clustering is done by 
sorting the polyA-site signals genome wide (reverse), travelling down the sorted list 
and attributing (clustering) signals in the region [-100, 25] nt to the considered 
polyA-site.  
PolyA sites were categorized based on presence of a preceding polyA 
signal into 4 classes with polyAR15: strong, weak, lacking polyA signal and non-
categorized sites. We examined the nucleotide composition, overlap with a 
published dataset of polyA-site 16 and efficiency of cleavage (cDNA counts) for 
each class of sites, which confirmed that the strong and weak sites were the most 
reliable sites in terms of known nucleotide composition around the polyA-site. 
Strong and weak polyA-site were used to define the position-dependent 
manner of polyA-site regulation by TDP-43. To avoid sites that result from inefficient 
cleavage, we employed additional filtering based on the relative site levels 
(summed across all experiments) within each gene as a measure of the strength of 
each site. Only polyA-site that exhibited >5% expression level compared to a major 
site for each gene were included. Since the alternative long 3’ UTRs are not always 
fully annotated, 5k of the intergenic region downstream of each gene were included 
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for this analysis (however only to the middle of the downstream gene if distance < 
5kb).  
 
5.17 IDENTIFYING DIFFERENTIALLY POLYADENYLATED GENES 
 
Genes included were those with two major polyA-site (highly expressed 
across both test and control). Next, polyA-site pairs were classified as same-exon, 
composite-exon or skipped-exon. For same-exon sites, the major site was 
compared to the sum of all other sites within the same exon (exon level). For 
composite-exon and skipped-exon pairs, we compare the major site to the 
expression of other sites in the gene. 
 
To estimate the level of change in expression between control and test 
groups, we look at the “percent change” (pc) score, which is calculated as follows: 
pc = controlPROXIMAL/controlPROXIMAL+DISTAL - testPROXIMAL/testPROXIMAL+DISTAL [-1, 1].  
 
Positive values determine a higher ratio of control vs test in proximal vs distal 
sites, and the negative value represent the opposite trend. Fisher’s exact test was 
then used to determine the significance of the change. We label genes as 
displaying significant changes in polyadenylation between test and control for which 
the Fisher’s p-value < 0.1. We then further classify the significant genes by looking 
at pc: repressed (pc < -0.1), enhanced (pc > 0.1) and controls (abs(pc) < 0.1 and 
p-value > 0.1).  GO-term analysis of TDP-43 regulated alternatively polyadenylated 
transcripts was performed using gene-ontology web interface 17. 
 
5.18 VISUALIZING POSITION-DEPENDENT POLYA SITE REGULATION 
WITH RNA-MAPS 
 
After identifying APA genes regulated by TDP-43 both in mouse and human 
ESCs, we took the 3 regulated sets of genes (repressed, enhanced and controls) 
and cumulatively plotted iCLIP data around polyA sites, marked with a red line at 
the center of the RNA-maps.  The whole RNA-map approach is similar to plotting 
RNA-maps around splice sites in the alternative-splicing context 18,19. We 
additionally plot heatmaps of the repressed and enhanced top 20 targets showing 
individual positional contributions to the cumulative RNA-map that are made 
available on the APAexpress webpage (www.apaexpress.org). These heat-maps 
are normalized by max target value. 
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5.19 RBPOME (RNA-RBP OCCUPANCY ASSAY) 
 
 The RBPome protocol was performed as in detail described previously20 with 
the following modifications. Per replicate ~50mio human embryonic stem cells were 
prepared in mTeSR pluripotency medium and cells were UV irradiated once with 
160 mJ/cm2 in a Stratlinker 1800 at 254 nm. For mouse ontogenetic RBPome I 
started with ~25mio cells if not indicated otherwise. Naïve, limes and epiSCs, cells 
were cultured in media described in 5.1. and UV irradiated once with 160 mJ/cm2 in 
a Stratlinker 1800 at 254 nm. PS progenitors were UV irradiated once with 160 
mJ/cm2 in a Stratlinker 1800 at 254 nm, followed by flow cytometry sorting of T-eGFP 
and FOXA2-RFP cell populations (gates were set accorting to naïve PSCs that don’t 
express differentiation markers T and FOXA2.  
 
5.20 MASS SPECTROMETRY 
 
Before loading, the samples were centrifuged for 5 minutes at 4°C. LC-MS/MS 
analysis was performed on a QExactive HF mass spectrometer (Thermo Scientific) 
online coupled to a Ultimate 3000 nano-RSLC (Thermo Scientific). Approximately 
0.5 µg of every digested sample was automatically injected and loaded onto the 
trap column at a flow rate of 30μl/min in 3% ACN/ 0.1% FA. After 5 min, the peptides 
were eluted from the trap column and separated on the C18 analytical column (75 
µm i.d. x 25 cm, Acclaim PepMap100 C18,2 µm, 100Å, Dionex) by a 90 min 
gradient from 5 to 25% ACN in 0.1% FA at 300 nl/min flow rate followed by a 5 min 
gradient from 25% to 40% ACN in 0.1% FA. Between each sample, the column was 
washed with 85% ACN for 5 min followed by equilibration at 3% ACN in 0.1% FA for 
18 min. MS spectra were recorded at a resolution of 60000 with an AGC target of 
3e6 and a maximum injection time of 50ms from 300 to 1500 m/z. From the MS 
scan, the 10 most abundant peptide ions were selected for fragmentation via HCD 
with a normalized collision energy of 27, an isolation window of 1.6 m/z and a 
dynamic exclusion of 30sec. MS/MS spectra were recorded at a resolution of 15000 
with a AGC target of 1e5 and a maximum injection time of 50ms. Intensity threshold 
was set to 1e4and unassigned charges and charges of +1 and >8 were excluded. 
 
5.21 FASP DIGEST 
 
Each 10µg of RBPome or total cell lysate were digested with a modified 
FASP procedure21. Briefly, the proteins were reduced and alkylated using 
dithiothreitol and iodoacetamide, diluted with one volume of UA buffer (8 M urea in 
0.1M Tris/HCl pH 8.5) and then centrifuged through a 30 kDa cut-off filter device 
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(PALL, Port Washington, USA). Samples were washed thrice with UA buffer and 
twice with 50 mM ammonium bicarbonate prior to digest of the immobilized proteins 
on the filter for 2 h at room temperature using 1 µg Lys-C (Wako Chemicals, Neuss, 
Germany) and for 16 h at 37°C using 2 µg trypsin (Promega, Mannheim, Germany). 
Tryptic peptides were collected by centrifugation (10 minutes at 14 000g), and the 
samples were acidified with 0.5% TFA and stored at -20 °C. 
 
5.22 LABEL-FREE ANALYSIS OF MRNA-INTERACTOME 
 
The acquired spectra were loaded to the Progenesis QI software (version 
2.0, Nonlinear Dynamics) for label free quantification and analyzed as described 
previously22. Briefly, profile data of the MS and MS/MS scans were transformed to 
peak lists with respective peak m/z values, intensities, abundances (areas under the 
peaks) and m/z width. After reference selection, the retention times of the other 
samples were aligned by automatic alignment to a maximal overlay of all features. 
After exclusion of all features with only one charge or more than seven charges, all 
remaining MS/MS spectra were exported as Mascot generic file and used for 
peptide identification with Mascot (version 2.5.1) in the Ensembl Human or Mouse 
protein database. Search parameters used were: 10 ppm peptide mass tolerance 
and 20 mmu fragment mass tolerance, one missed cleavage allowed, 
carbamidomethylation was set as fixed modification, methionine oxidation and 
asparagine or glutamine deamidation were allowed as variable modifications. A 
Mascot-integrated decoy database search calculated an average false discovery of 
1% when searches were performed with a mascot percolator score cut-off of 13 and 
an appropriate significance threshold p. Peptide assignments were re-imported into 
the Progenesis QI software and the abundances of all peptides allocated to each 
protein were summed up. Resulting normalized protein abundances were used 
further and compared to existing mRNA-interactome datasets obtained from HeLa23 
and HEK293 cells24.  As the aim of this study was not to expand the repertoire of 
RBPs in hESC, but rather to determine the dynamics of high confidence RBPs 
bound to mRNAs, we used only the overlap between published and our datasets 
(388 high confidence RBPs) for further analysis of mRNA interactome changes upon 
gain of paraspeckels (NEAT1ΔpA-site vs control hESC).   
 
5.23 MS IDENTIFICATION OF DYNAMIC RNA BINDING PROTEINS 
 
RBPome measurments provided us with raw RNA-occupancy measurements 
for individual proteins in investigated pluripotent and PS- states. To test whether 
observed changes in RBPome in fact only reflect changes in proteins’ overall 
abundance during development, we in parallel measured the total cellular 
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proteomes from biological triplicates of naïve PSCs, limes PSCs, EpiSCs and 
purified T-eGFP/FOXA2-RFP progenitors. Using 2-peptide criterion for proteome 
data, we detected 3172 of which 519 were in common with individual state 
RBPomes (naïve, limes and epiblast respectively). As the RBPome is a measure of 
RNA occupancy and proteome is a measure of total protein levels, the log 
differences between states represent fold-changes in raw RNA occupancy and 
protein levels respectively. As both measurements are in linear relation to input 
levels, change in RNA occupancy reflects change in protein levels providing 
consistent RNA binding activity of RBP. The log differences between RBPome 
measurements (ΔRBPome) and proteome levels (ΔProteome) are thus expected to 
remain comparable for a majority of proteins as factors governing inherent RNA 
binding (e.g. proteins’ affinity, expression of RNA targets, changes in complex 
formation) will in general remain stable. Some minor perturbations are expected due 
to morphological changes in the cells experiencing naïve to epiblast transition – in 
particular enlargement of cytoplasm and corresponding increase in total and/or 
cytoplasmic RNA quantity. Skewed ΔProteome/ΔRBPome ratio across biologically 
relevant pluripotent state-pairs indicates with high probability towards a 
developementally regulated dynamic RNA binding activity.  
 
At the start of the analysis that was performed together with Valter Bergant we, 
to remove possible remaining contaminants, filtered data for proteins intersecting at 
least two of the naïve, limes and primed pluripotent mRNA interactomes (Fig 19). 
Applying generalized linear model with 1/variance as a weighting factor to the 
combined data generated a series of coefficients (equations for reference and 
m&ms). The last coefficient in the set describes discrepancy between change in 
mRNA occupancy (mRNA interactome) and change in proteome levels between 
pairs of pluripotent states – the previously mentioned ΔProteome/ΔRBPome ratio. 
The model also generated probabilities of coefficients being equal to zero, meaning 
change in RNA interactome was in concordance with change in Proteome. The P 
values were adjusted using Hommel method. Proteins that had adjusted P values 
<0.05 were assigned to dynamic mRNA interactome of a pair of states (N:L - 16, 
N:E – 77, L:E – 99, E:T – 124) 
 
𝑃 𝑥 (𝑠𝑡𝑎𝑡𝑒1) = 𝑃 𝐼 (𝑠𝑡𝑎𝑡𝑒1) + 𝑘1 
𝑅 𝑥 (𝑠𝑡𝑎𝑡𝑒1) = 𝑃 𝑥 (𝑠𝑡𝑎𝑡𝑒1) + 𝑘2 = (𝑃 𝐼 (𝑠𝑡𝑎𝑡𝑒1) + 𝑘1) + 𝑘2 
𝑃 𝑥 (𝑠𝑡𝑎𝑡𝑒2) = 𝑃 𝑥 (𝑠𝑡𝑎𝑡𝑒1) + 𝑘3 = (𝑃 𝐼 (𝑠𝑡𝑎𝑡𝑒1) + 𝑘1) + 𝑘3 
𝑅 𝑥 𝑠𝑡𝑎𝑡𝑒2 = 𝑅 𝑥 𝑠𝑡𝑎𝑡𝑒1 + 𝑘3 + 𝑘4 = 𝑃 𝐼 𝑠𝑡𝑎𝑡𝑒1 + 𝑘1 + 𝑘2 + 𝑘3 + 𝑘4 
___________________________________________________________________________________________________ 
𝑃,𝑅 − 𝑃𝑟𝑜𝑡𝑒𝑜𝑚𝑒 𝑎𝑛𝑑 𝑅𝐵𝑃𝑜𝑚𝑒 𝑙𝑜𝑔2 𝑣𝑎𝑙𝑢𝑒𝑠 
𝑥, 𝐼 − 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑥 𝑎𝑛𝑑 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝐼𝑛𝑡𝑒𝑟𝑐𝑒𝑝𝑡 
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𝑠𝑡𝑎𝑡𝑒1, 𝑠𝑡𝑎𝑡𝑒2 − 𝑎𝑟𝑏𝑖𝑡𝑟𝑎𝑟𝑦 𝑝𝑙𝑢𝑟𝑖𝑝𝑜𝑡𝑒𝑛𝑡 𝑠𝑡𝑎𝑡𝑒𝑠, 𝑒.𝑔. 𝑛𝑎𝑖𝑣𝑒 𝑎𝑛𝑑 𝑝𝑟𝑖𝑚𝑒𝑑 
𝑘1, 𝑘2, 𝑘3, 𝑘4 − 𝑐𝑜𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑡𝑠 𝑜𝑓  𝑙𝑚: 
𝑘1 = 𝑓(𝑝𝑟𝑜𝑡𝑒𝑖𝑛) 
𝑘2 = 𝑓(𝑑𝑎𝑡𝑎𝑠𝑒𝑡)(𝑝𝑟𝑜𝑡𝑒𝑖𝑛) 
𝑘3 = 𝑓(𝑠𝑡𝑎𝑡𝑒)(𝑝𝑟𝑜𝑡𝑒𝑖𝑛) 
𝑘4 = 𝑓(𝑑𝑎𝑡𝑎𝑠𝑒𝑡)(𝑠𝑡𝑎𝑡𝑒)(𝑝𝑟𝑜𝑡𝑒𝑖𝑛) 
___________________________________________________________________________________________________ 
𝐷𝑦𝑛 =  𝑃 𝑠𝑡𝑎𝑡𝑒1 − 𝑃 𝑠𝑡𝑎𝑡𝑒2 −  𝑅 𝑠𝑡𝑎𝑡𝑒1 − 𝑅 𝑠𝑡𝑎𝑡𝑒2  
𝐷𝑦𝑛 = 𝑃 𝐼 𝑠𝑡𝑎𝑡𝑒1 + 𝑘1 − 𝑃 𝑥 𝑠𝑡𝑎𝑡𝑒1 + 𝑘1 + 𝑘3 − (𝑃 𝐼 𝑠𝑡𝑎𝑡𝑒1 + 𝑘1 + 𝑘2
− 𝑃 𝑠𝑡𝑎𝑡𝑒𝐼 1 + 𝑘1 + 𝑘2 + 𝑘3 + 𝑘4 ) 
𝐷𝑦𝑛 = 𝑃 𝐼 𝑠𝑡𝑎𝑡𝑒1 + 𝑘1 − 𝑃 𝑥 𝑠𝑡𝑎𝑡𝑒1 + 𝑘1 + 𝑘3 − (𝑃 𝐼 𝑠𝑡𝑎𝑡𝑒1 + 𝑘1 + 𝑘2
− 𝑃 𝑠𝑡𝑎𝑡𝑒𝐼 1 + 𝑘1 + 𝑘2 + 𝑘3 + 𝑘4 ) 
𝐷𝑦𝑛 = −𝑘3 − (− 𝑘3 + 𝑘4 ) 
𝐃𝐲𝐧 = 𝐤𝟒 
___________________________________________________________________________________________________ 
  
Dyn - a measure of differential polyA RNA occupancy of a RBP, relative to protein 
levels 
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